Continuous cultures of fused cells secreting antibody of predefined specificity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1975-08

AUTHORS

G. KÖHLER, C. MILSTEIN

ABSTRACT

THE manufacture of predefined specific antibodies by means of permanent tissue culture cell lines is of general interest. There are at present a considerable number of permanent cultures of myeloma cells1,2 and screening procedures have been used to reveal antibody activity in some of them. This, however, is not a satisfactory source of monoclonal antibodies of predefined specificity. We describe here the derivation of a number of tissue culture cell lines which secrete anti-sheep red blood cell (SRBC) antibodies. The cell lines are made by fusion of a mouse myeloma and mouse spleen cells from an immunised donor. To understand the expression and interactions of the Ig chains from the parental lines, fusion experiments between two known mouse myeloma lines were carried out. More... »

PAGES

495-497

Journal

TITLE

Nature

ISSUE

5517

VOLUME

256

Related Patents

  • Methods Of Identifying Latent Splice Sites
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Scd Fingerprints
  • Lung Cancer Biomarkers
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Bh3 Peptides And Method Of Use Thereof
  • Method For Antiphospholipid Syndrome
  • Phosphospecific Chemokine Receptor Antibodies
  • Compositions And Methods For Cancer
  • Luca2 And Antibodies That Bind Thereto
  • Human Fetal Bladder-Derived Epithelial Cells
  • Compositions And Methods For Screening And Using Compounds Antagonizing Spore-Surface Interactions
  • Therapy Targeting Flt4 (Veger-3) Expressed In Blood Vessels
  • Antibodies Directed Against Amyloid-Beta Peptide And Methods Using Same
  • Cd44 Polypeptides, Polynucleotides Encoding Same, Antibodies Directed Thereagainst And Method Of Using Same For Diagnosing And Treating Inflammatory Diseases
  • Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors
  • Targeted Delivery To Legumain-Expressing Cells
  • Detection And Modulation Of Cancer Stem Cells
  • Infectious Clone Of Human Parvovirus B19 And Methods
  • Live Cell Biosensors
  • A Long Qt Syndrome Gene Which Encodes Kvlqt1 And Its Association With Mink
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Cross-Screening System And Methods For Detecting A Molecule Having Binding Affinity For A Target Molecule
  • Uncharacterized Orf3 In Sars-Coronavirus Is A Cyclic-Amp-Dependent Kinase And A Target For Sars Therapy
  • Antibodies To Oncostatin M Receptor
  • Transferrin Receptor Antibodies
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Flavivirus Detection Methods Employing Recombinant Antigens Comprising A Japanese Encephalitis (Jev) Signal Sequence
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Method For Measurement Of Hepatitis C Virus
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Methods And Means For The Production Of Ig-Like Molecules
  • Cd47 Antibodies And Methods Of Use Thereof
  • Monoclonal Antibodies That Bind B7h6 And Uses Thereof
  • Microbubbles For Affinity Separation
  • Mutations In Ion Channels
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Methods And Compositions For Diagnosing Osteoarthritis In A Feline
  • Histone Deacetylases, And Uses Related Thereto
  • Method Of Producing 4-1bb Binding Molecules And Associated Nucleic Acids
  • Perlecan Fragments As Biomarkers Of Bone Stromal Lysis
  • Identification Of Agents For Treating Calcium Disorders And Uses Thereof
  • Identification Of Antigen Or Ligand-Specific Binding Proteins
  • Diagnostic And Therapeutic Epitope, And Transgenic Plant
  • Amino Acid Sequence Presenting Fusion Polypeptide And Its Use
  • An Antibody Specifically Binding To Insulin-Like Growth Factor-1
  • Methods And Assays For Measuring P95 And/Or P95 Complexes In A Sample And Antibodies Specific For P95
  • Method For Producing Antigen-Specific Antibodies Via In Vitro Immunisation
  • Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Immunizing Compositions And Methods Of Use
  • Human Cytomegalovirus Neutralising Antibodies And Use Thereof
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Comt1 Gene Fiber-Specific Promoter Elements From Poplar
  • Neutralizing Anti-Influenza A Virus Antibodies And Uses Thereof
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Prothymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses, And Pharmaceutical Compositions Comprising This Antibody
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Early Thymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Method For Generating And Screening An Antibody Library
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Polarization Sensitive Optical Coherence Tomography System
  • Method For Increasing Granulocyte Number In A Patient By Administering Superactive Il-33 Fragments
  • Serum Albumin Binding Molecules
  • Expression Vectors
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Camptothecin Conjugates Of Anti-Cd22 Antibodies For Treatment Of B Cell Diseases
  • Antibodies To Receptor For Advanced Glycation End Products (Rage) And Uses Thereof
  • Combination Treatment Of Pancreatic Cancer
  • Assays For Detecting Antibodies Specific To Therapeutic Anti-Ige Antibodies And Their Use In Anaphylaxis
  • Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens
  • Therapeutic Dll4 Binding Proteins
  • Means And Methods For Diagnosing Cancer Using An Antibody Which Specifically Binds To Braf V600e
  • Tet2 As A New Diagnostic And Pronostic Marker In Hematopoietic Neoplasms
  • Unsymmetrical Pyrrolobenzodiazepines-Dimers For Use In The Treatment Of Proliferative And Autoimmune Diseases
  • Pan-Selectin Inhibitor With Enhanced Pharmacokinetic Activity
  • Isolating Human Antibodies
  • Anti-Trop-2 Antibody-Drug Conjugates And Uses Thereof
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Active Immunization Using A Siderophore Receptor Protein
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Peptide Nanostructures Encapsulating A Foreign Material And Method Of Manufacturing Same
  • Method To Determine Metastatic Potential Of Tumor Cells
  • An Anti-Hiv Protein, Tap 29, From Trichosanthes, Dna Coding Therefor And Therapeutic Uses Thereof
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Methods For Ligation And Uses Thereof
  • Novel C3c Epitope, Antibodies Binding Thereto, And Use Thereof
  • Fgf21 Polypeptides Comprising Two Or More Mutations
  • Isolation, Detection, Diagnosis And/Or Characterization Of Circulating Trop-2-Positive Cancer Cells
  • Histone Deacetylase And Tubulin Deacetylase Inhibitors
  • Induced Activation In Dendritic Cells
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Automatic Stent Detection
  • Methods And Compositions For Synthesis Of Nucleic Acid Molecules Using Multiple Recognition Sites
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Methods For Generating Radioimmunoconjugates
  • Ddr1-Binding Agents And Methods Of Use Thereof
  • Human Monoclonal Antibodies To Human Nucleolin
  • Compositions And Methods For Diagnosing And Treating Phenylketonuria (Pku)
  • Glycated Cd59 Peptides, Their Preparation, And Uses Thereof
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Allelic Disorders Caused By Mutations In Trpv4
  • Human Fgf Receptor And Β-Klotho Binding Proteins
  • Anti-Lymphotoxin
  • Immobilized Immunoglobulin-Binding Proteins
  • High Affinity Monoclonal Antibodies To Bowman-Birk Inhibitor And Immunoassay Methods
  • Monoclonal Antibody That Recognizes A Structure Common To Human Interleukin-2 (Tcgf) And To The Light Lambda Chain Of Human Immunoglobulin And Lines Of Hybridoma Cells That Produce These Monoclonal Antibodies
  • Chromatin Regulator Genes
  • Method Of Detecting Native Probnp
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Methods For Making Compositions Including Gram Negative Microbial Polypeptides
  • Methods For Generating Or Increasing Revenues From Crops
  • Inhibitors Of Autophosphorylation Protein Kinases
  • Human Vanilloid Receptor Vr3 Protein
  • Monoclonal Antibodies Reactive With Human Breast Cancer
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Methods And Reagents For Determining Protein S
  • Bgl4 Β-Glucosidase And Nucleic Acids Encoding The Same
  • Lysin-Deficient Bacteriophages Having Reduced Immunogenicity
  • Proteins Encoded By Polynucleic Acids Of Porcine Reproductive And Respiratory Syndrome Virus (Prrsv)
  • Modified Adamts4 Molecules And Method Of Use Thereof
  • Dnas Encoding Guinea Pig Histamine Receptors Of The H4 Subtype
  • Sulfotransferase Sequence Variants
  • Nucleotide Sequence Of Mammastatin And Methods Of Use
  • Human Pancreatic Epithelial Progenitor Cells And Methods Of Isolation And Use Thereof
  • Active Immunization Using A Siderophore Receptor Protein
  • Mutations Associated With Iron Disorders
  • Apo-2 Ligand
  • Substitutional Variants Of Apo-2 Ligand
  • Method For The Analysis Of Soluble Analytes
  • Methods Of Inhibiting Osteoclastogenesis
  • Human Chromogranin A (Cga) Immunologic Assay, Antibodies, Reagents And Kits For Said Assay
  • Method For Targeted Delivery Of Nucleic Acids
  • Monoclonal Antibodies Against Human Protein Mcm3, Process For Their Production, And Their Use
  • Host Defense Enhancement
  • Nuclear Matrix Protein Fluid Assay
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Methods Of Obtaining Compositions Enriched For Hematopoietic Stem Cells, Compositions Derived Therefrom And Methods Of Use Thereof
  • Process For Inhibiting Complement Activation Via The Alternative Pathway
  • Chimeric Mammals With Human Hematopoietic Cells
  • Interleukin-1 Receptor Antagonist And Recombinant Production Thereof
  • Methodologies For The Detection Of Human Immunodeficiency Virus Nucleic Acids Employing Oligonucleotide Primer Derived From The Hiv-1 Mvp5180/91 Genome
  • Methods And Materials Relating To Cd39-Like Polypeptides
  • Anti-Ige Antibodies And Method Of Improving Polypeptides
  • Lipoprotein Lipase Suppression By Endotoxin-Induced Mediator (Shock Assay)
  • Identification Of Agents That Protect Against Inflammatory Injury To Neurons
  • Anticancer Compounds And Methods
  • Down-Regulation And Silencing Of Allergen Genes In Transgenic Peanut Seeds
  • Streptococcus Pneumoniae Proteins And Nucleic Acid Molecules
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Method Of Identifying Compounds That Modulate Human Histamine H3 Receptor
  • Detection Of Hypoxia
  • Methods For Producing Members Of Specific Binding Pairs
  • Human Kinase And Polynucleotides Encoding The Same
  • Antibody To Aminoterminal Propeptide Of Type 1 Procollagen, And Assay Method Using It
  • Treatment For Inflammatory Bowel Disease With Vla-4 Blockers
  • Β3 Integrin Subunit Specific Polypeptides, Cdnas Which Encode These Polypeptides And Methods Of Producing These Polypeptides
  • Immunological Detection Method
  • Hme1 Nucleic Acids And Probes
  • Aminoterminal Propeptides Of Typed 1 Procollagen
  • Anti-Αvβ3 Integrin Antibody Antagonists
  • Single Chain Trimers And Uses Therefor
  • Methods And Compositions For The Generation And Use Of Conformation-Specific Antibodies
  • Anti-Human Vegf Antibodies With Unusually Strong Binding Affinity To Human Vegf-A And Cross Reactivity To Human Vegf-B
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Producing Immunogenic Constructs Using Soluble Carbohydrates Activated Via Organic Cyanylating Reagents
  • Purification Of Human Chorionic Gonadotropin Β-Core Molecule And Preparation Of Antibodies With Specificity For Same
  • Monoclonal Antibodies To Pdgf
  • Hybridomas Producing Monoclonal Antibodies Specific For Felv P27
  • Acute Leukemia And Lymphoblastic Lymphoma-Specific Cd43 Epitope And Use Thereof
  • Conjugates Of Cell Binding Molecules With Cytotoxic Agents
  • Method For Detection Of Methylthioadenosine Phosphorylase Deficiency In Mammalian Cells
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Method For Inducing Cell Death In Acute Lymphoblastic Leukemic System Cells
  • Notch1 Binding Agents And Methods Of Use Thereof
  • Systems For Correcting Distortions In A Medical Image And Methods Of Use Thereof
  • Modified Polynucleotides Encoding Granulysin
  • Antibody-Drug Conjugates And Uses Thereof
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Modified Polynucleotides For Treating Galactosylceramidase Protein Deficiency
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Human Calcium Dependent Proteases, Polynucleotides Encoding The Same, And Uses Thereof
  • Methods Of Imaging And Treatment With Targeted Compositions
  • Methods And Compounds For Detection Of Molecular Targets
  • Filip1l Nucleic Acid Fragments
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Diagnosis Of Liver Pathology Through Assessment Of Protein Glycosylation
  • Epha2 As A Therapeutic Target For Cancer
  • Streptococcus Pyogene Antigens
  • Compositions Comprising Chimeric Ospa Molecules And Methods Of Use Thereof
  • Diagnosis Of Liver Pathology Through Assessment Of Anti-Gal Igg Glycosylation
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Anti-Ed-A Immunoconjugates For Inflammatory Bowel Disease
  • Methods For Detecting Oncofetal Fibronectin
  • Anti-T. Cruzi Antibodies And Methods Of Use
  • Vertebrate Smoothened Antibodies
  • Methods Of Testing Cancer Cells And Anticancer Drugs
  • Deacetylase Inhibitors And Uses Thereof
  • Application Of Mrna For Use As A Therapeutic Against Tumor Diseases
  • Method For Preparing Monoclonal Antibody To Hbsag
  • Monoclonal Anti-Idiotype Antibodies
  • Human Monoclonal Antibodies Against Bacterial Toxins
  • Production Of Proteins In Glutamine-Free Cell Culture Media
  • Monoclonal Antibody Therapy For Pancreas Cancer
  • T-Cell Receptor Cdr3 Peptides And Antibodies
  • Notch1 Receptor Binding Agents And Methods Of Use Thereof
  • Telescopic Side Port Catheter Device With Imaging System And Method For Accessing Side Branch Occlusions
  • Polymorphisms In The Human Gene For The Multidrug Resistance-Associated Protein 1 (Mrp-1) And Their Use In Diagnostic And Therapeutic Applications
  • Klebsiella Antigens
  • Human Telomerase Catalytic Subunit
  • Modified Plasminogen Activator Inhibitor Type-1 Molecule And Methods Based Thereon
  • B. Anthracis Prevention And Treatment: Mutant B. Anthracis Lacking Luxs Activity And Furanone Inhibition Of Growth, Ai-2 Quorum Sensing, And Toxin Production
  • Immune-Compromised Transgenic Mice Expressing Human Hepatocyte Growth Factor (Hhgf)
  • Collectin
  • Tes7 And Antibodies That Bind Thereto
  • Therapeutic Method For Reducing Angiogenesis
  • Nucleic Acid Molecules Encoding Transmembrane Serine Proteases, The Encoded Proteins And Methods Based Thereon
  • Methods For The Diagnosis And Treatment Of Epilepsy
  • Immunoglobulins Devoid Of Light Chains
  • Tumor Associated Antigen, Peptides Thereof, And Use Of Same As Anti-Tumor Vaccines
  • Transgenic Mice Expressing Antibodies Specific For Genes Of Interest And Uses Thereof
  • Method And Kits For Detecting Cerebrospinal Fluid In A Sample
  • Antibody To Telomerase Reverse Transcriptive
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Human Anti-Opgl Neutralizing Antibodies As Selective Opgl Pathway Inhibitors
  • Multiple Signaling Pathways Induced By Hexavalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Neutralizing Anti-Influenza A Virus Antibodies And Uses Thereof
  • Quantitation Of Cellular Dna And Cell Numbers Using Element Labeling
  • Bifunctional Histone Deacetylase Inhibitors
  • Antibodies Directed Against Amyloid-Beta Peptide And Methods Using Same
  • Chimeric Vegf Peptides
  • Methods, Antibodies And Kits For Detecting Cerebrospinal Fluid In A Sample
  • S-Adenosyl-L-Methionine Analogs With Extended Activated Groups For Transfer By Methyltransferases
  • Cd44 Polypeptides, Polynucleotides Encoding Same, Antibodies Directed Thereagainst And Method Of Using Same For Diagnosing And Treating Inflammatory Diseases
  • Micropatterning Of Molecular Surfaces Via Selective Irradiation
  • Cytotoxic Compounds And Conjugates
  • Diagnostic Method For Epilepsy
  • Methods For Modifying Surfaces
  • Plant Centromere Compositions
  • Arl-1 Specific Antibodies
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Treatment Of Celiac Disease With Iga
  • Preprimitive Streak And Mesendoderm Cells
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Lymphokine In The Pure State, Monoclonal Antibodies, Hybridoma Cell Lines, Processes And Applications
  • Monoclonal Antibody Against Human Manganese-Superoxide Dismutase, Method For Producing The Monoclonal Antibody, Assay Reagent Or Assay Kit And Assay Method By Use Thereof, And Diagnostic Method Of Human Ovarian Cancer And Myocardial Infarction By Use Thereof
  • Monoclonal Antibodies To Anthracyclines
  • Methods For Treating Progressive Multiple Sclerosis
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Simultaneous Imaging, Monitoring, And Therapy
  • Anti-Cxcl1, Cxcl7 And Cxcl8 Antibodies And Their Applications
  • Constructs Targeting Afp Peptide/Mhc Complexes And Uses Thereof
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Cell-Permeable Probes For Identification And Imaging Of Sialidases
  • Engineered Antibodies And Other Fc-Domain Containing Molecules With Enhanced Agonism And Effector Functions
  • Methods Of Treatment Using Antibodies Which Bind Il-17a And Il-17f
  • Isolation Of Adult Multipotential Cells By Tissue Non-Specific Alkaline Phosphatase
  • Monoclonal Antibodies Specific For Serogroup W Of N. Meningitidis And Uses Thereof In Diagnosis
  • Anti-Hepcidin Antibodies And Uses Thereof
  • Albumin Binding Antibodies And Binding Fragments Thereof
  • Antibody Producing Non-Human Mammals
  • Hydrophilic Self-Immolative Linkers And Conjugates Thereof
  • Modified J-Chain
  • Method To Generate Antibodies To Ion Channels
  • Modified Caspase Polypeptides And Uses Thereof
  • Antibodies Capable Of Binding To The Coagulation Factor Xi And/Or Its Activated Form Factor Xia And Uses Thereof
  • Antibodies To Risperidone Haptens And Use Thereof
  • Treatment Of Cancer By Manipulation Of Commensal Microflora
  • Generation Of Binding Molecules
  • Lamin A, An Activator Of Longevity/Anti-Aging Sirt1 Protein
  • Rm2 Antigens And Use Thereof
  • Diagnosis Of Liver Pathology Through Assessment Of Protein Glycosylation
  • Automatic Image Playback
  • Method Of Screening For Compounds That Disaggregate Amyloid Aggregates
  • Antibody Molecules Which Bind Il-17a And Il-17f
  • Heparanase Specific Molecular Probes And Their Use In Research And Medical Applications
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Methods For Treating Obesity Using Fibroblast Growth Factor-Like Polypeptides
  • Antibodies That Bind Specifically To Phosphorylated Β-Catenin
  • Chimeric Vegf Peptides
  • Severe Acute Respiratory Syndrome Dna Compositions And Methods Of Use
  • Progenitor Endothelial Cell Capturing With A Drug Eluting Implantable Medical Device
  • Methods Of Screening For Neoplastic Disease States
  • Vesiculins
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Variant Hypocrea Jecorina Cbh1 Cellulase
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Adam-9 Modulators
  • Recombinant Glycoproteins Related To Feline Thyrotropin
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Antibody Molecules Having Specificity For Human Il-6
  • Nucleic Acids Encoding Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Induced Activation In Dendritic Cells
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Γ-Secretase Substrates And Methods Of Use
  • Method For The Treatment Of T Cell Mediated Conditions By Depletion Of Icos-Positive Cells In Vivo
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Aptamers Against The Myelin Basic Protein As Neuroprotective Agents
  • Antibodies And Pharmaceutical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins
  • 4-1bb Binding Molecules
  • Human Rhinovirus (Hrv) Antibodies
  • Ephb3-Specific Antibody And Uses Thereof
  • Methods For Detecting Antibody That Specifically Bind A Siderophore Receptor Polypeptide
  • Inhibitors Of The Epidermal Growth Factor Receptor-Heat Shock Protein 90 Binding Interaction
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Human G-Protein Chemokine Receptor Hsatu68
  • Bcrf1 Antagonists For Treating Epstein-Barr Virus Infections
  • Method For Diagnosing Neurodegenerative Diseases
  • Methods Of Immuno-Analysis Using Monoclonal Antibodies
  • Monoclonal Antibody And Process For Its Preparation
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Regulatable Growth Of Filamentous Fungi
  • Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonist
  • Class- And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Targeted Thrombosis
  • Knockout Animals Manifesting Hyperlipidemia
  • Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors
  • Composition And A Reagent For Ctla - 4, And Uses Thereof
  • Parenterally Administrable Drug Having Thrombolytic Activity And Containing Protein C
  • Immunological Detection Method
  • Monoclonal Antibodies For Differentiating Pathogenic And Nonpathogenic E. Histolytica
  • Inhibitors Of Platelet Binding
  • Sequential Peptide And Oligonucleotide Syntheses Using Immunoaffinity Techniques
  • Oncolytic Viruses And Methods For Treating Neoplastic Disorders
  • Engineered Nucleic Acids Encoding A Modified Erythropoietin And Their Expression
  • Cdna Encoding A Gene Bog (B5t Over-Expressed Gene) And Its Protein Product
  • Genes Associated With Posttraumatic-Stress Disorder (Ptsd)
  • Lipid Membrane Structure Containing Anti-Mt-Mmp Monoclonal Antibody
  • Cellular Permissivity Factor For Viruses, And Uses Thereof
  • Bgl5 Β-Glucosidase And Nucleic Acids Encoding The Same
  • Anti-Hepcidin Antibodies And Uses Thereof
  • Diagnostic Antibody Assay
  • Device And Methods For The Detection Of Cervical Disease
  • Materials And Methods For Assay Of Anti-Hepatitis C Virus (Hcv) Antibodies
  • Monoclonal Antibody Stro-4
  • N-11 Truncated Amyloid-Beta Aβ11-X Monoclonal Antibodies And Compositions
  • Glycan-Interacting Compounds
  • Bcr-Abl Truncation Mutations
  • Use Of Antibodies Against Specific Mhc-Peptide Complexes
  • Thyronamine Derivatives And Analogs And Methods Of Use Thereof
  • Method For The Prognosis And Treatment Of Cancer Metastasis
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Tgf-Beta-Specific Antibodies And Methods Of Use Thereof For Treatment
  • Immunogenic Polypeptide Isolated From Mycobacterium Avium Subspecies Paratuberculosis And Uses Thereof
  • Composition And Method For The Diagnosis And Treatment Of Diseases Associated With Neurite Degeneration
  • Anti-T. Cruzi Antibodies And Methods Of Use
  • Cd47 Antibodies And Methods Of Use Thereof
  • Multi-Component Inhibitors Of Nucleic Acid Polymerases
  • Methods For Measuring Platelet Reactivity Of Individuals Treated With Drug Eluting Stents
  • Cellular Permissivity Factor For Viruses And Uses Thereof
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Method Of Enriching For Pancreatic Endoderm Cells
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Hybrid Expression Of Neisserial Proteins
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Susceptibility Variants For Peripheral Arterial Disease And Abdominal Aortic Aneurysm
  • Antibodies To Aripiprazole Haptens And Use Thereof
  • Cancerous Disease Modifying Antibodies
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Trop-2
  • Method For Production Of Cleistogamous Rice And Method For Selection Of Cleistogamous Rice
  • Regulation Of Transcription Factor, Nf-Il6/Lap
  • Application Of Mrna For Use As A Therapeutic Agent For Tumorous Diseases
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Cancerous Disease Modifying Antibodies
  • Antibodies Against Human Or Mouse Il-21 Receptor
  • Fusion Partner Cells And Uses Thereof
  • Cancerous Disease Modifying Antibodies
  • Method For Detecting The Expression Of An Envelope Protein Of A Human Endogenous Retrovirus And Uses Of A Gene Coding For Said Protein
  • Chimeric Ospa Proteins And Methods Of Use Thereof
  • Antibody Specifically Binding To Insulin-Like Growth Factor-1
  • Glycan-Interacting Compounds
  • Monoclonal Antibody
  • Lipoprotein Associated Phospholipase A2, Inhibitors Thereof And Use Of The Same In Diagnosis And Therapy
  • Multiplexed Protein Expression And Activity Assay
  • Methods Of Detecting Brca1 Mutations
  • Monoclonal Antibodies Against The Plasmin-Antiplasmin Complex, A Method For The Preparation Thereof And The Use Thereof
  • Epha2 Monoclonal Antibodies And Methods Of Making And Using Same
  • Β-Amyloid Peptide-Binding Proteins And Polynucleotides Encoding The Same
  • Methods Of Inhibiting T-Cell Dependent Proliferation Of Peripheral Blood Lymphocytes Using The Cd2-Binding Domain Of Lymphocyte Function Associated Antigen 3
  • Novel Compounds
  • Use Of Dr6 And P75 Antagonists To Promote Survival Of Cells Of The Nervous System
  • Human Anti-Opgl Neutralizing Antibodies As Selective Opgl Pathway Inhibitors
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Cbh1 Homologs And Varian Cbh1 Cellulase
  • Methods For Enhanced Protein Production
  • Epha2 As A Therapeutic Target For Cancer
  • Combinatorial Biomarkers For Clinical Applications In Lung Cancer Patient Management
  • Pegylation Of Recombinant Blood Coagulation Factors In The Presence Of Bound Antibodies
  • Therapeutic Tb Vaccine
  • Conformational-Specific Antibodies Against A[Β] Oligomers
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Anti-Α Synuclein Binding Molecules
  • Cancerous Disease Modifying Antibodies
  • Human M2e Peptide Immunogens
  • Methods Of Diagnosing Clostridium Difficile Infection
  • Dna Encoding Antibody Molecules Having Specificity For Human Il-6
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Mutant Citrobacter Freundii Phytase Polypeptide
  • Protein Kinase Ck2 Gene Mutations, Amplifications And Polymorphisms In Human Cancers And Methods Of Use
  • Dipeptide Analogs For Treating Conditions Associated With Amyloid Fibril Formation
  • Treatment Of Protein Degradation Disorders
  • Methods For Prediction Of Clinical Outcome To Epidermal Growth Factor Receptor Inhibitors By Non-Small Cell Lung Cancer Patients
  • Cancerous Disease Modifying Antibodies
  • Anti-Cd20 Antibodies And Fusion Proteins Thereof And Methods Of Use
  • Method For Generating Active Antibodies Against A Resistance Antigen, Antibodies Obtained By Said Method And Their Uses
  • Methods For Identifying Factors For Differentiating Definitive Endoderm
  • Disease Susceptibility
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Prothymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses, And Pharmaceutical Compositions Comprising This Antibody
  • Method For The Preferential Formation Of Hybrid Cells Making A Desired Antibody
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Methods For Enriching For Pancreatic Endocrine Cells
  • Methods Of Treating Cancer By Administering An Axl Ligand-Binding Portion Of An Axl Tyrosine Kinase Receptor Extracellular Domain
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Method For Detecting Transcription Factor-Protein Interactions
  • Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/Pathogen-Derived Antigen Complexes And Uses Thereof
  • Novel Methods For The Stabilisation Of Immunoglobulin Constant Domains
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Methods For Inducing Selective Apoptosis
  • Multivalent Fibronectin Based Scaffold Domain Proteins
  • Methods And Compositions For Screening And Detecting Biomarkers
  • Aegyptin And Uses Thereof
  • Modified Polynucleotides Encoding Apoptosis Inducing Factor 1
  • Haptens Of Olanzapine
  • High Concentration Antibody And Protein Formulations
  • Identification Of Antigen Or Ligand-Specific Binding Proteins
  • Pharmaceutical Composition Containing Core Factor Involved In Proliferation And Differentiation Of Central Nervous Cell
  • Combination Therapy With Anti-Cd74 And Anti-Cd20 Antibodies Provides Enhanced Toxicity To B-Cell Diseases
  • Anti-Idiotypic Antibody And Its Use In Diagnosis And Therapy In Hiv-Related Disease
  • Producing Immunogenic Constructs Using Soluable Carbohydrates Activated Via Organic Cyanylating Reagents
  • Anti-Asialo-Gm1 Monoclonal Antibodies And Method Of Use
  • Nucleic Acids Encoding Inactive Variants Of Human Telomerase
  • Fgf 21 Polypeptides Comprising Two Or More Mutations And Uses Thereof
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Methods And Reagents For Diagnosing Rheumatoid Arthrtis
  • Anti-Igf-Ir Antibodies And Uses Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Glycan-Interacting Compounds And Methods Of Use
  • Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
  • Methods For Early Detection Of Heart Disease
  • Monoclonal Antibodies To Placental Isoferritin For Use In Detecting Oncofetal Ferritin Associated With Breast Cancer And Hodgkins Disease
  • Modified Sendai Virus Vaccine And Imaging Vector
  • Compositions And Methods For The Treatment Of Sepsis
  • Artificial Cell Constructs For Cellular Manipulation
  • Reactive Labelling Compounds And Uses Thereof
  • Methods For Testing Anti-Thrombotic Agents
  • Antibodies To Risperidone And Use Thereof
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Monoclonal Antibody To Human Helper T Cells, Method Of Preparing It, Hybrid Cell Line Producing It, Its Diagnostic And Therapeutic Uses And Diagnostic And Therapeutic Compositions Comprising It
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Monocyte Antigen, Antibody, And Methods
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Antibodies To The E1 Extracellular Loop Of Ion Channels
  • Allelic Disorders Caused By Mutations In Trpv4
  • Human Monoclonal Anti-Pd-L1 Antibodies And Methods Of Use
  • Anti-Angiogenic Therapy
  • Progenitor Endothelial Cell Capturing With A Drug Eluting Implantable Medical Device
  • Transgenic Non-Human Animals For Producing Chimeric Antibodies
  • Microporous Materials, Methods Of Making, Using, And Articles Thereof
  • Regulatable Growth Of Filamentous Fungi
  • Method Of Treating A Patient For Pain By Administering An Anti-Ion Channel Antibody
  • Cynomolgus Gp80 Receptor And Uses Thereof
  • Immunizing Composition And Method For Inducing An Immune Response Against The Beta-Secretase Cleavage Site Of Amyloid Precursor Protein
  • Assay For Cardiac Troponin-T (Ctnt)
  • Methods For Preparing Sequencing Libraries
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Polypeptide
  • Immunogenic Peptides Derived From Sclerostin
  • Sclerostin-Binding Antibodies
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Inhibitors Of Complement Activation
  • Human Kunitz-Type Inhibitor With Enhanced Antifibrinolytic Activity
  • Methods For Prognosticating Progression Or Long Term Non-Progression Of A Hiv Infection Or Hiv-Associated Disorders In A Patient
  • Method Of Using A Polynucleotide Encoding 2.5-Diketo-D-Gluconic Acid Reductase
  • Nucleic Acids Coding For Adhesion Factors Of Group B Streptococcus, Adhesion Factors Of Group B Streptococcus And Futher Uses Thereof
  • Diagnostic And Therapeutic Applications Of Soluble Lhcgr Protein
  • Process For The Production Of Monoclonal Antibodies
  • Flavivirus Immunogens Comprising Extracellular Viral Particles Composed Of The Premembrane (Prm) And Envelope (E) Antigens
  • Prostate Cancer Diagnosis And Treatment
  • Detection Of Human Antibodies To Squalene In Serum
  • Recombinant Anti-Vla4 Antibody Molecules
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Prostate Cancer Diagnosis And Treatment
  • Compositions And Methods For The Treatment And Prevention Of Hyperproliferative Diseases
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Method Of Detecting A Subfraction Of Probnp
  • Method For Screening A Library Of Vhh Polypeptides
  • Use Of The Transcription Of The Slug Gene In Evaluating The Redisposition Of A Subject With Cancer To Develop Metastatis
  • Angiogenesis Inhibiting Molecules And Their Use In The Treatment And Diagnosis Of Cancer
  • Compositions And Methods For Cancer
  • Methods Of Use Of Antibodies Which Recognize A Protease Cleavage Site Of An Lap Fragment Of Tgf-Β
  • Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonist Antibody
  • Method For The Diagnosis And Prognosis Of Malignant Diseases
  • Methods For Treating Obesity Using Fibroblast Growth Factor-Like Polypeptides
  • Modified Amylases From Pseudomonas Species
  • Basb006 Polynucleotide(S) And Polypeptides From Neisseria Meningitis
  • Cystine Knot Molecules
  • Her-2 Binding Antagonists
  • Human Monoclonal Antibodies Against Hendra And Nipah Viruses
  • Gastrin Hormone Immunoassays
  • Nucleic Acids Encoding Chimeric Flavivirus Immunogens Comprising The Japanese Encephalitis Virus (Jev) Prm Signal Sequence
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Antibodies Directed Against Amyloid-Beta Peptide And Nucleic Acids Encoding Same
  • Soluble Erbb3 Methods Of Detection And Antibodies
  • Antibodies That Bind To Cancer-Associated Antigen Cd46 And Methods Of Use Thereof
  • Regulatable Growth Of Filamentous Fungi
  • Nephropathy-Associated Gene
  • Soluble Erbb3 And Treatment Of Cancer
  • Immunoglobulins Devoid Of Light Chains
  • Influenza Virus Vaccine Composition And Methods Of Use
  • Assays For Cancer Patient Monitoring Based On Levels Of Analyte Components Of The Plasminogen Activator System In Body Fluid Samples
  • Mhc-Peptide Complex Binding Ligands
  • Compositions And Methods For Treatment Of Severe Acute Respiratory Syndrome (Sars)
  • Correction Of Alpha-1-Antitrypsin Genetic Defects Using Spliceosome Mediated Rna Trans Splicing
  • Peptide Nanostructures And Methods Of Generating And Using The Same
  • Biomarkers Of Liver Injury
  • Cellular Permissivity Factor For Viruses And Uses Thereof
  • Anti-Cd20 Antibodies And Fusion Proteins Thereof And Methods Of Use
  • Methods For Detecting Targets
  • Combination Therapy With Anti-Cd74 Antibodies Provides Enhanced Toxicity To Malignancies, Autoimmune Disease And Other Diseases
  • Method Of Providing Disease-Specific Binding Molecules And Targets
  • Human Serum Albumin Linkers And Conjugates Thereof
  • Binding Polypeptides And Uses Thereof
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Monoclonal Antibodies That Bind B7h6 And Uses Thereof
  • Antibody Molecules Having Binding Specificity For Human Il-13
  • Sgp130/Fc Dimers
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Tumors
  • Data Structure Of An Image Storage And Retrieval System
  • Cell Culture Compositions
  • Methods And Systems For Using Rfid In Biological Field
  • Methods And Systems For Using Rfid In Biological Field
  • Anti-Pd-L1 Antibodies And Uses Therefor
  • Variant Hypocrea Jercorina Cbh1 Cellulases
  • Klebsiella Antigens
  • Fgf21 Mutants Multimers And Uses Thereof
  • Collectin
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Methods Of Determining Patient Response By Measurement Of Her-3
  • Aegyptin And Uses Thereof
  • Antibodies That Recognize Cutting Edge Within The Tgf-Β Activation Controlling Region
  • Methods, Products And Treatments For Diabetes
  • Homeobox Gene
  • Chimeric Polypeptides And Uses Thereof
  • Compounds
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Diseases Associated With Wounded Or Inflamed Tissue
  • Peptide-Based Passive Immunization Therapy For Treatment Of Atherosclerosis
  • Variant Hyprocrea Jecorina Cbh1 Cellulases
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Human Antibodies Specific For Gastrin Materials And Methods
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Carbonic Anhydrase Ix (G250) Anitbodies
  • Antibodies That Bind To Epha2 And Methods Of Use Thereof
  • Monoclonal Antibodies To Progastrin
  • Transgenic Non-Human Animals For Producing Chimeric Antibodies
  • Compositions And Methods For Binding Lysophosphatidic Acid
  • Anti-Plgf Antibody
  • Methods And Compositions For Detection Of Ehrlichia Chaffeensis (P120)
  • System And Method Of Registering Field Of View
  • Compositions And Methods For Angiogenesis-Related Molecules And Treatments
  • Anti-Ngf Antibodies And Methods Using Same
  • Biomarker For Replicative Senescence
  • Predictive Marker Of Dnmt1 Inhibitor Therapeutic Efficacy And Methods Of Using The Marker
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Antibodies To Il-1 R1 And Methods Of Making Them
  • Synthesis And Intermediates Of Pyrrolobenzodiazepine Derivatives For Conjugation
  • Gene And Mutations Thereof Associated With Seizure And Movement Disorders
  • Membrane Evaporation For Generating Highly Concentrated Protein Therapeutics
  • Cereblon Isoforms And Their Use As Biomarkers For Therapeutic Treatment
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Multispecific Antibodies
  • Human Inkt Cell Activation Using Glycolipids With Altered Glycosyl Groups
  • Markers For The Prediction Of Outcome Of Anthracycline Treatment
  • Methods For Treating, Diagnosing, And Monitoring Lupus
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Method Of Treatment For Leukemia Using An Anti-Il1rap Antibody
  • Method Of Treating A Solid Tumor With Il1rap Antibodies
  • Variant Enzymes
  • Methods For Modifying Human Antibodies By Glycan Engineering
  • Neutralizing Monoclonal Antibodies Against The Nogo-66 Receptor (Ngr) And Uses Thereof
  • Methods For The Treatment Of Cancer And Inflammatory Diseases Using Cereblon As A Predictor
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Nt-Procnp As A Biomarker Of Vascular Disorders And Pregnancy Complication
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Proteins With Modified Glycosylation And Methods Of Production Thereof
  • Cross-Reactive Staphylococcus Aureus Antibody
  • Methods For Inducing Partial Apoptosis Using Caspase Polypeptides
  • Methods And Compositions For Prostate Cancer Metastasis
  • Pyrrolobenzodiazepine—Antibody Conjugates
  • Isolated Dna Sequences Encoding, And Methods For Making, Antibody Molecules Having Binding Specificity For Human Il-13
  • Anti-Alpha Synuclein Binding Molecules
  • Trem2 Cleavage Modulators And Uses Thereof
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Methods Of Producing Immunoglobulins, Vectors And Transformed Host Cells For Use Therein
  • Method Of Using Cd2-Binding Domain Of Lymphocyte Function Associated Antigen 3 To Initiate T Cell Activation
  • Monoclonal Antibody To Human Glicentin, Hybridoma For Producing Said Antibody And Assay Method For Human Glicentin Using Said Antibody
  • Human Monoclonal Antibody Neutralizing Vascular Endothelial Growth Factor Receptor And Use Thereof
  • Modified Polynucleotides Encoding Cited4
  • New Methods For Treatment Of Inflammatory Diseases
  • Modified Polynucleotides For The Production Of Nuclear Proteins
  • Methods And Kits For Diagnosing Tumorigenicity
  • Modified Polynucleotides Encoding Septin-4
  • Automatic Calibration Systems And Methods Of Use
  • Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors
  • Bcr-Abl Variants
  • Use Of Nucleoside Derivatives Comprising A Citrate Group For The Production Of Antibodies Having An Affinity For Triphosphorylated Nucleosides
  • Tcr-V-Beta Related Peptides For Treatment And Diagnosis Of Autoimmune Disease
  • Method For Production Of Bioresorbable Microparticles, Microparticles Thus Obtained And Use Thereof
  • Mutant Citrobacter Freundii Phytase Polypeptide
  • Variant Buttiauxella Sp. Phytases Having Altered Properties
  • Isolated Antibodies Against Biologically Active Leptin-Related Peptides
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Cetp Fragments
  • Hla-Restricted, Peptide-Specific Antigen Binding Proteins
  • Methods For Increasing Definitive Endoderm Production
  • Methods For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Mutant Protein Capable Of Binding Specifically And Quickly To Troponin I Derived From Human Myocardium
  • Plants Modified With Mini-Chromosomes
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Methods And Systems For Transforming Luminal Images
  • Human Anti-Pd-1 Antibodies And Uses Therefor
  • Modulators Of Intracellular Chloride Concentration For Treating Down Syndrome
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Antigen-Presenting Complex-Binding Compositions And Uses Thereof
  • Pharmaceutical Compositions That Modulate Hptpbeta Activity
  • Affinity Structures For The Specific Binding Of Substances By Not - Covalent Showed Interaction Forms
  • Raag10 Cell Surface Target And A Family Of Antibodies Recognizing That Target
  • Mutant 2,5-Diketo-L-Gluconic Acid Reductases
  • Recombinant Bifunctional Protein Of Human Lutropin Receptor And Human Chorionic Gonadotropin B-Subunit And Uses Thereof
  • Induction Of Apoptosis And Cell Growth Inhibition By Protein 4.33
  • Differentially Expressed Tumour-Specific Polypeptides For Use In The Diagnosis And Treatment Of Cancer
  • Use Of A Polypeptide For Detecting, Preventing Or Treating A Pathological Condition Associated With A Degenerative, Neurological Or Autoimmune Disease
  • Cancer Biomarkers
  • Bacterium Causing Poultry Disease And Vaccine Derived Thereof
  • Antibodies To The Human Prolactin Receptor
  • Compositions And Methods For The Rapid Growth And Detection Of Microorganisms
  • Preparing Hapten-Specific Antibodies And Their Application For Immunodiagnostics And Research
  • Uses Of Fgf21 Polypeptides Comprising Two Or More Mutations
  • Antibodies Against Cxcr4 And Methods Of Use Thereof
  • Methods Of Modulating Immune Function
  • Hyaluronidase And Factor Viii Compositions
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Hcv Ns3 Recombinant Antigens And Mutants Thereof For Improved Antibody Detection
  • Chimeric Ospa Genes, Proteins And Methods Of Use Thereof
  • Compositions And Methods For Growth Factor Modulation
  • Cyclic Peptides As Adam Protease Inhibitors
  • Biomarkers For Type 2 Diabetes
  • Iconic Communication
  • Anti-Cmet Antibody
  • Compositions For Inhibiting Masp-2 Dependent Complement Activation
  • Fusion Constructs And Use Of Same To Produce Antibodies With Increased Fc Receptor Binding Affinity And Effector Function
  • Methods For Determining Drug Efficacy Using Cereblon-Associated Proteins
  • Bh3 Peptides And Method Of Use Thereof
  • Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Methods For Making Antibody Molecules Having Specificity For Human Il-6
  • Anti-Mesothelin Antibodies
  • Clec14a Inhibitors
  • Amyloid Precursor-Like Protein And Uses Thereof
  • Producing Immunogenic Constructs Using Soluble Carbohydrates Activated Via Organic Cyanylating Reagents
  • Bovine Leptin Protein, Nucleic Acid Sequences Coding Therefor And Uses Thereof
  • Methods Of Inhibiting Type 2 Vascular Endothelial Growth Factor Receptors Using Polypeptides
  • Methods For Producing Members Of Specific Binding Pairs
  • Nucleic Acids Encoding An Enediyne Polyketide Synthase Complex
  • Anti-Cd26 Antibodies And Methods Of Use Thereof
  • Cancerous Disease Modifying Antibodies
  • Lipoprotein Associated Phospholipase A2, Inhibitors Thereof And Use Of The Same In Diagnosis And Therapy
  • Methods Of Eliciting Broadly Neutralizing Antibodies Targeting Hiv-1 Gp41
  • Monoclonal Antibodies Which Bind (E)-5- (2-Bromovinyl)-Arabinofuranosyluracil And Diagnostic Methods Based Thereon
  • Neisseria Meningitidis Antigenic Polypeptides, Corresponding Polynucleotides And Protective Antibodies
  • Multiple Antigenic Peptides Immunogenic Against Streptococcus Pneumonia
  • Method For Reducing Adverse Effects Of A Human 70kda Mediator Which Results From Endotoxin Stimulation Of Macrophages
  • Modulation Of Drug Resistance Via Ubiquitin Carboxy-Terminal Hydrolase
  • Monoclonal Antibody And Antigens Specific Therefor And Methods Of Using Same
  • Method For Targeted Delivery Of Nucleic Acids
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Apo-2-Receptor
  • Cloned Dna Encoding Mammalian Occludins
  • Human Medical Treatment By Aerosol Inhalation Of Immunoglobulin A
  • Methods Of Immuno Analysis Using Monoclonal Antibodies
  • Antigenic Material, Antibodies Raised Thereto, Hybridomas For Producing Antibodies, And Immunoassays Incorporating Such Antibodies
  • Monoclonal Antibody Against Pentacyclic Oleanan-Type Triterpene And Use Thereof
  • Producing Monoclonal Antibodies Against Human T-Cell Receptor Elements Using Recombinant Dna Vectors
  • Producing Monoclonal Antibodies Against Human T-Cell Receptor Elements Using Recombinant Dna Vectors.
  • Preparation Of Factor Ix
  • Method Of Producing Aminoterminal Propeptide Of Type 1 Procollagen
  • Anti-Ige Antibodies And Methods Of Improving Polypeptides
  • Sulfonylurea Receptor Trangenic Rodents
  • Tyramine Compounds And Their Neuronal Effects
  • Cd2-Binding Domain Of Lymphocyte Function Associated Antigen-3
  • Antibodies Against A Host Cell Antigen Complex For Pre And Post Exposure Protection From Infection By Hiv
  • Protein-Polysaccharide Conjugate Vaccines And Other Immunological Reagents Prepared Using Homobifunctional And Heterobifunctional Vinylsulfones, And Processes For Preparing The Conjugates
  • Pdes And Uses Thereof
  • Compositions And Methods For Identifying Agents Which Regulate Autolytic Processes In Bacteria
  • Dnas Encoding Rat Histamine Receptors Of The H4 Subtype
  • Icbp90 Polypeptide And Its Fragments And Polynucleotides Coding For Said Polypeptides And Applications For Diagnosing And Treating Cancer
  • Phage-Display Of Immunoglobulin Heavy Chain Libraries
  • Bcrf1 Antagonists For Treating Epstein-Barr Virus Infections
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Actinium-225 Complexes And Conjugates For Targeted Radiotherapy
  • Apo-2 Ligand
  • Compositions And Methods For Regulating Autolytic Processes In Bacteria
  • Efficient Synthesis Of Protein-Oligonucleotide Conjugates
  • Cdna Encoding A Gene Bog (B5t Over-Expressed Gene) And Its Protein Product
  • 2,5-Diketo-L-Gluconic Acid Reductases And Methods Of Use
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Prodrugs Activated By Targeted Catalytic Proteins
  • Use Of Protein C Or The Activation Peptide Of Protein C For Preparing A Pharmaceutical Preparation
  • Immunological Detection Methods
  • Peptide Library Formats And Methods Relating Thereto
  • Composition Containing The P40 Subunit Of Interleukin-12
  • Methods For The Production Of Antibodies And Induction Of Immune Responses To Tumor-Associated Gangliosides By Immunization With Ganglioside Lactones
  • Immunoassays Empolying Generic Anti-Hapten Antibodies And Materials For Use Therein
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Methods For The Production Of Antibodies And Induction Of Immune Responses To Tumor-Associated Ganagliosides By Immunization With Gangloiside Lactones
  • Serum Albumin Binding Molecules
  • Hcv Core Lipid Binding Domain Monoclonal Antibodies
  • Chimeric Mammals With Human Hematopoietic Cells
  • Virulence-Attenuating Genetic Deletions
  • Methods For Converting Glucose To Ascorbic Acid
  • Down-Regulation And Silencing Of Allergen Genes In Transgenic Peanut Seeds
  • Tes7 And Antibodies That Bind Thereto
  • Bispecific Egfr/Igfir Binding Molecules
  • Porcine Circovirus Type 2 Vaccines
  • Compositions And Methods For Treating Pigmentary Conditions And Melanoma
  • Stem Cell Factor Inhibitor
  • Methods Of Purifying Anti A Β Antibodies
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Selective Binding Agents Of Telomerase
  • Automated System For Combining Bright Field And Fluorescent Microscopy
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Antibodies To Quetiapine And Use Thereof
  • Anti-Htra1 Antibodies And Methods Of Use
  • Compositions And Methods For Modulating Dnmt1 Inhibitor Activity
  • Conjugate Molecules
  • Histone Deacetylases, And Uses Related Thereto
  • Iconic Communication
  • Binding Proteins That Bind To Human Fgfr1c, Human Β-Klotho And Both Human Fgfr1c And Human Β-Klotho
  • Methods For Detecting Oncofetal Fibronectin
  • Antihuman Stromelysin Monoclonal Antibody And Diagnosis Of Rheumatoid Arthritis By Enzyme Immunoassay
  • Transgenic Organisms And Cells, And Methods Of Producing Transgenic Organisms And Cells
  • New Mammal Protein Having An Immunomodulating And Progestational Activity
  • Immunoassay Method For Small Molecules
  • Antibody Reactive To Hamster Immunoglobulins And Assay Using Same
  • Antibodies To A4 Amyloid Peptide
  • Method Of Assaying Immunization Stimulating Activity
  • Monoclonal Anti-Alpha-Amylase Antibody Which Non-Specifically Inhibits The Enzyme Activity Of Human Alpha-Amylase
  • Modified Polynucleotides For Treating Protein Deficiency
  • Crh Responsive Genes In Cns
  • Polynucleotide And Polypeptide Sequences Of Monkey Cathepsin S
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Use Of A Polypeptide For Detecting, Preventing Or Treating A Pathological Condition Associated With A Degenerative, Neurological Or Autoimmune Disease
  • Methods For Treating Mastitis In A Milk Producing Animal
  • Anti Cxcr4 Antibodies And Their Use For The Treatment Of Cancer
  • Combination Of Angiopoietin-2 Antagonist And Of Vegf-A, Kdr And/Or Flt1 Antagonist For Treating Cancer
  • Csf3r Polypeptides And Uses Thereof
  • B. Anthracis Prevention And Treatment: Mutant B. Anthracis Lacking Luxs Activity And Furanone Inhibition Of Growth, Ai-2 Quorum Sensing, And Toxin Production
  • Antibodies To Opgl
  • A Monoclonal Antibody Against Human Tau - Protein
  • Isolation Of Adult Multipotential Cells By Tissue Non-Specific Alkaline Phosphatase
  • Methods For Treating Pain By Administering A Nerve Growth Factor Antagonist And An Nsaid And Compositions Containing The Same
  • Antibody Drug Conjugates (Adc) That Bind To Cd37 Proteins
  • Polypeptides And Use Thereof
  • Modified Polynucleotides For The Production Of Proteins Associated With Human Disease
  • Antibody Cocktail
  • Immunogenic Fusion Polypeptides
  • Biomarkers For Systemic Lupus Erythematosus
  • Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Use Of Dr6 And P75 Antagonists To Promote Survival Of Cells Of The Nervous System
  • Diagnostic And Therapeutic Target For Autoimmune Diseases And Uses Thereof
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Medical Device With Coating For Capturing Genetically-Altered Cells And Methods For Using Same
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Decreasing Lactate Level And Increasing Polypeptide Production By Downregulating The Expression Of Lactate Dehydrogenase And Pyruvate Dehydrogenase Kinase
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells Of A Companion Animal That Express An Activating Receptor And Cells That Express B7-H3 And Uses Thereof
  • Compositions Comprising Polyglutamic Acid Nanoparticles And Cd40 Agonists
  • Cell Growth-Promoting Peptide And Use Thereof
  • Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
  • Combination Of Human Cytomegalovirus Neutralizing Antibodies
  • Method Of Treating Cardiac Arrhythmia With Long Acting Atrial Natriuretic Peptide(La-Anp)
  • Targeting Construct Comprising Anti-Polymer Antibody And Contrast/Therapeutic Agents Binding To The Same
  • Assay For Measurement Of Antibodies Binding To A Therapeutic Monoclonal Antibody
  • Human Chondroitinase Glycoprotein (Chasegp), Process For Preparing The Same, And Pharmaceutical Compositions Comprising Thereof
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Multiple Signaling Pathways Induced By Hexvalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Nucleic Acid Molecule Encoding A Specific Il-1r1 Antibody
  • Stable Compositions For Nucleic Acid Amplification And Sequencing
  • M-Csf-Specific Monoclonal Antibody And Uses Thereof
  • Assay For Diagnosis Of Cardiac Myocyte Damage
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Methods And Systems For Using Rfid In Biological Field
  • Method For Producing Immortalised Antibodies-Secreting Cells
  • Chimeric Flavivirus Immunogens Comprising The Japanese Encephalitis Virus (Jev) Prm Signal Sequence
  • Immunizing Compositions And Methods Of Use
  • Anti-Mesothelin Antibodies
  • Surface Protein (Hbsag) Variant Of The Hepatitis B Virus
  • Antibodies Specific For Tgf-Beta And Methods For Treating Thereof
  • Pd-1 Antibodies
  • Autoantibody Enhanced Immunoassays And Kits
  • Anti Eotaxin-2 Antibodies That Recognize Additional Ccr3-Binding Chemokines
  • Method Of Treating Age-Related Macular Degeneration Comprising Administering A Compstatin Analog
  • B7-H3l Cell Surface Antigen And Antibodies That Bind Thereto
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Anti-Baff Antibodies
  • Human Cytomegalovirus Neutralising Antibodies And Use Thereof
  • Tumor Necrosis Factor-Gamma
  • Anti-Mesothelin Antibodies
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus
  • Compositions And Methods Relating To Stop-1
  • Use Of A Polypeptide To Detect, Prevent Or Treat A Pathological State Associated With A Degenerative, Neurological, Autoimmune Illness
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Immunoassay Method And Kit To Be Used Therein
  • Vascular Tumor Markers
  • Assay For Sars Coronavirus By Amplification And Detection Of The Replicase Sequence
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd63
  • Antibodies And Pharmaceutical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins
  • Monoclonal Antibodies Reactive With Endotoxin Core
  • Hcv Antigen-Antibody Combination Assay And Methods And Compositions For Use Therein
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Neukinase, A Downstream Protein Of Neuregulin
  • Chimeric Peptides Comprising Her-2 B-Cell Epitopes And T-Helper Epitopes
  • Methods And Systems For Characterizing A Cellular Constituent Using Response Profiles
  • Fgf21 Mutants And Uses Thereof
  • Immuno-Pet Imaging Of Antibodies And Immunoconjugates And Uses Therefor
  • Anti Human Immunodeficiency Antibodies And Uses Thereof
  • Hedgehog Pathway Modulation And Uses Thereof For Treating, Preventing And/Or Diagnosing Cancer
  • Antibodies Directed To Angiopoietin-1 And Angiopoietin-2 And Uses Thereof
  • Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Antibodies Inhibiting C-Met Dimerization And Uses Thereof
  • Par4 Inhibitor Therapy For Patients With Par4 Polymorphism
  • Modified Polynucleotides Encoding Copper Metabolism (Murr1) Domain Containing 1
  • Antibodies To Human Programmed Death Receptor Pd-1
  • Beta Secretase Polypeptides
  • Antibodies, Recombinant Antibodies, Recombinant Antibody Fragments And Fusions Mediated Plant Disease Resistance Against Fungi
  • Method Of Detecting And Treating Tuberous Sclerosis Complex Associated Disorders
  • Modulators Of Itch Ubiquitinase Activity
  • Antibodies To A Non-Ligand Binding Region Of At Least Two Notch Receptors
  • Composition And Method For Diversification Of Target Sequences
  • Antibodies That Bind To Repulsive Guidance Molecule A (Rgma)
  • Dock-And-Lock (Dnl) Complexes For Therapeutic And Diagnostic Use
  • Methods For Treating Hematopoietic Malignancies
  • Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
  • Method To Generate Antibodies To Ion Channels
  • Fgf-21 Mutants Comprising Polyethylene Glycol And Uses Thereof
  • Influenza Virus Vaccine Composition And Methods Of Use
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Thermostable Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Microarrays And Uses Therefor
  • Peptides Directed For Diagnosis And Treatment Of Amyloid-Associated Diseases
  • Prostate-Specific Gene For Diagnosis, Prognosis And Management Of Prostate Cancer
  • Genetic Markers Associated With Risk Of Diabetes Mellitus
  • Chondrosarcoma Associated Genes
  • Hepatocyte Growth Factor Receptor Antagonists And Uses Thereof
  • Hybrid Immunoglobulin-Thrombolytic Enzyme Molecules Which Specifically Bind A Thrombus, And Methods Of Their Production And Use
  • Nucleic Acid Preparation Methods
  • Immobilization Of Biologically Active Substances With Carrier Bond Antibody
  • Mutations In Ion Channels
  • Hybridomas And Monoclonal Paratopic Molecules To Apolipoprotein A-I
  • Human Inkt Cell Activation Using Glycolipids
  • Methods For Treating Colon Cancer And Inflammation Associated With Overexpression Of Human Signal Peptide-Containing Proteins
  • 2,5-Diketo-L-Gluconic Acid Reductases And Methods Of Use
  • Methods And Kits For Diagnosing Tumorigenicity And Determining Resistance To The Antineoplastic Effects Of Antiestrogen Therapy
  • Copd Diagnosis
  • Methods And Compositions For Inhibiting The Growth Of Hematopoietic Malignant Cells
  • Notch1 Receptor Antibodies And Methods Of Treatment
  • Polynucleotides Encoding Notch Receptor Antibodies
  • Anti-Cmet Antibody
  • Methods For Treating Edema By Administering A Soluble Hyaluronidase Glycoprotein (Shasegp)
  • Light Emitting Microorganisms And Cells For Diagnosis And Therapy Of Tumors
  • Secreted Proteins
  • Compositions Relating To A Mutant Clostridium Difficile Toxin And Methods Thereof
  • Neisseria Meningitidis Composition And Methods Thereof
  • Compositions And Methods Useful For Stabilizing Protein-Containing Formulations
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Monoclonal-Antibody-Producing Hybrid Cell Line, Antibody And Method Of Preparing It, Therapeutic Composition Containing It And Its Diagnostic And Therapeutic Uses
  • Monoclonal Antibody To Human Helper T Cells, Method Of Preparing It, Hybrid Cell Line Producing It, Its Diagnostic And Therapeutic Uses And Diagnostic And Therapeutic Compositions Comprising It
  • Method Of Determining Virus Removal From A Sample Containing A Target Protein Using Activated Carbon
  • Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use
  • Compositions And Methods For Growth Factor Modulation
  • Chimeric Peptides Comprising Her-2 B-Cell Epitopes And Tcell Helper Epitopes
  • Antibodies Against The Rgm A Protein And Uses Thereof
  • Methods For The Prognosis Of Breast Cancer
  • Modified Polynucleotides For The Production Of Proteins
  • Method Of Treating Cancer By Administering Egfr And Egfr/Igfir Binding Molecules
  • Multicomponent Immunogenic Composition For The Prevention Of Beta-Hemolytic Streptococcal (Bhs) Disease
  • Anti-Il-23 Heterodimer Specific Antibodies
  • Recombinant Antibodies Against Hepatitis C Virus And Methods Of Obtaining And Using Same
  • Ror1-Binding Molecules, And Methods Of Use Thereof
  • Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/Pathogen-Derived Antigen Complexes And Uses Thereof
  • Antibody Molecules Having Specificity For Human Ox40
  • Methods And Compositions For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
  • Antibodies To Receptor For Advanced Glycation End Products (Rage) And Uses Thereof
  • Immunoassay Of Analytes In Samples Containing Endogenous Anti-Analyte Antibodies
  • Histone Deacetylases, And Uses Related Thereto
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Peptides Derived From A Retrovirus Of The Hiv Group And Their Use
  • Mass Spectrometric Methods And Products
  • Β-Trcp1, Β-Trcp2 And Rsk1 Or Rsk2 Inhibitors And Methods For Sensitizing Target Cells To Apoptosis
  • Anti-Cmet Antibody
  • Therapeutic Dll4 Binding Proteins
  • Monoclonal Antibodies Against Hmgb1
  • Bifunctional Histone Deacetylase Inhibitors
  • Detection And Quantitation Of Full-Length Thioredoxin (Trx) And Truncated Thioredoxin (Trx 80) In Complex Samples
  • Peptides And Methods Using Same For Diagnosis And Treatment Of Amyloid-Associated Disease
  • Pd-1 Antibody
  • Anti Human Interleukin-1 Receptor Accessory Protein (Il1 Rap) Antibodies And Uses Thereof
  • Antibody-Active Agent Conjugates And Methods Of Use
  • Molecules, Compositions, Methods And Kits For Applications Associated With Flaviviruses
  • Method For Detection Of L523s Expression In Biological Samples
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • Stable Antibody Containing Compositions
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Non-Competitive Immunoassay For Small Analytes
  • A Cd44vra Antibody And Diagnostic And Therapeutic Methods Using Same
  • Cellular Permissivity Factor For Viruses And Uses Thereof
  • Compositions And Methods For The Treatment Of Tumor Of Hematopoietic Origin
  • Methods Of Generating High-Production Of Antibodies From Hybridomas Created By In Vitro Immunization
  • Methods For Producing Members Of Specific Binding Pairs
  • Branched Molecular Scaffolds For Linking Polymer Residues To Biologically Active Moieties
  • Antibodies To Gm-Csf
  • Human Kunitz-Type Inhibitor With Enhanced Antifibrinolytic Activity
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Trop-2
  • Expression Control Using Variable Intergenic Sequences
  • Nucleic Acid Vaccines For Prevention Of Flavivirus Infection
  • Polyene Polyketides, Processes For Their Production And Their Use As A Pharmaceutical
  • Modified Dendritic Cells Having Enhanced Survival And Immunogenicity And Related Compositions And Methods
  • Means And Methods For Treating Or Preventing Brain Tumors Based On The Nuclear Receptor Tailless (Tlx)
  • Mass Spectrometric Methods And Products
  • Polynucleotides Encoding Antibodies Directed Against Amyloid-Beta Peptide
  • Cancerous Disease Modifying Antibodies
  • Hxhv Virus, Nucleic Material, Peptide Material And Uses
  • Process For The Determination Of Inflammatory Processes And Pharmaceutical Compositions For The Treatment Thereof
  • Purification Of Proteins With Cationic Surfactant
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Compositions And Methods For Growth Factor Modulation
  • Lafora's Disease Gene
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Microorganisms For Therapy
  • Antibodies To Aripiprazole And Use Thereof
  • Fgf21 Mutants Comprising A Mutation At Position 98, 171 And/Or 180
  • Antibodies To Olanzapine And Use Thereof
  • Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
  • Methods And Nucleic Acids For Analyses Of Cellular Proliferative Disorders
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Methods For Treating Progressive Multiple Sclerosis
  • Dipeptide Analogs For Treating Conditions Associated With Amyloid Fibril Formation
  • Methods For Treating Il-6 Mediated Diseases With Antibody Molecules Specific For Il-6
  • Compositions And Methods For Diagnosing And Treating Community-Acquired Methicillin-Resistant Staphylococcus Aureus
  • Human Antigen Binding Proteins That Bind Β-Klotho, Fgf Receptors And Complexes Thereof
  • Targeting Metastasis Stem Cells Through A Fatty Acid Receptor (Cd36)
  • Fibronectin Based Scaffold Proteins Having Improved Stability
  • Hydrophilic Self-Immolative Linkers And Conjugates Thereof
  • Antibodies For The Treatment Of Hiv
  • Micropositioning Cells For Tissue Engineering
  • Class-And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • A Subject Of Mammal, Having, In Particular, An Immunomodulator Activity And Progestational, Antibodies, Their Preparation And Their Application
  • Virulence-Attenuating Genetic Deletions Deleted From Mycobacterium Bcg
  • Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf) Neutralizing Antibodies
  • Antibodies To Interleukin-6
  • Formulation And Delivery Of Plga Microspheres
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • System And Method For Oct Depth Calibration
  • Fgf Mutants With Reduced Proteolysis And Aggregation
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Methods And Nucleic Acids For The Analysis Of Gene Expression Associated With The Development Of Prostate Cell Proliferative Disorders
  • Cancer Platinum Resistance Detection And Sensitization Method
  • Sgp130/Fc Dimers For Treatment Of Inflammatory Disease
  • B7-H3l Cell Surface Antigen And Antibodies That Bind Thereto
  • Human Mullerian Duct-Derived Epithelial Cells And Methods Of Isolation And Uses Thereof
  • Plant Centromere Compositions
  • Methods And Compounds For Modulating Male Fertility
  • Method For Controlling O-Desulfation Of Heparin And Compositions Produced Thereby
  • Nucleic Acid Fragment Encoding An Nrps For The Biosynthesis Of Anthramycin
  • Bacterial Xylanases
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Mitigating Tissue Damage And Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (Ltbp4)
  • Antibody Cocktail
  • Human Ovarian Mesothelial Cells And Methods Of Isolation And Uses Thereof
  • Methods Of Treating Disorders By Administration Of F11 Receptor Antagonists
  • Anti-Bv8 Antibodies And Uses Thereof
  • Antimicrobial Peptide And Use Thereof
  • Controlled Platelet Activation To Monitor Therapy Of Adp Antagonists
  • Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
  • Compositions And Methods Of Altering Cholesterol Levels
  • F11 Receptor (F11r) Antagonists As Therapeutic Agents
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Early Thymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Hybrid Cell Line For Producing Complement-Fixing, Monoclonal Antibody To Human Suppressor T Cells, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Monoclonal Antibodies To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Cd40-Related Receptor That Binds Cd40l
  • Nucleic Acids Encoding Rearranged Human Immunoglobulin Sequences From Transgenic Transchromosomal Mice
  • Assay Of Isomerised And/Or Optically Inverted Proteins And Protein Fragments
  • Methods For Reducing Fecal Shedding
  • Mutant 2.5-Diketo-L-Gluconic Acid Reductases
  • Methods Of Testing Cancer And Anticancer Drugs
  • Nuclear Matrix Protein Fluid Assay
  • Anti-Ige Antibodies And Method Of Improving Polypeptides
  • Targeted Contrast Agents For Diagnostic And Therapeutic Use
  • Monospecific Antibodies Against A Subunit Of Fibrinogen
  • Preparation Of Factor Ix
  • Antibodies To Flt4, A Receptor Tyrosine Kinase And Uses Thereof
  • Monoclonal Antibody Against Pentacyclic Oleanan-Type Triterpene And Use Thereof
  • Antigenic Material, Antibodies Raised Thereto, Hybridomas For Producing Antibodies, And Immunoassays Incorporating Such Antibodies
  • Antibodies To Human Cancer Nucleolar Antigen Pl20, Corresponding Cell Lines, And Their Preparation And Use In The Detection Of Human Cancer Cells
  • Use Of Monoclonal Antibodies Against Bacterial Adhesins
  • Antibody Hybrid Molecules And Process For Their Preparation
  • Monoclonal Antibodies Reactive With Shared Idiotypes On Human Antibodies To Native Dna From Patients With Systemic Lupus Erythematosus
  • Method For Removal Of Human Antibodies To Native Dna From Serum
  • Monoclonal Antibody, Measuring Method Of Glucosylated Protein By Utilizing The Monoclonal Antibody, And Kit Therefor
  • Assays For Shiga Toxin And Shiga-Like Toxins
  • Pulsatile Delivery Of Leptin Receptor Ligands
  • Method To Ameliorate Osteolysis And Metastasis
  • Reagents And Methods For The Detection And Quantification Of Testosterone In Fluid Samples
  • Methods Of Screening For Persistent Hyperinsulinemic Hypoglycemia Of Infancy
  • Phage-Display Of Immunoglobulin Heavy Chain Libraries For Identification Of Inhibitors Of Intracellular Constituents
  • Monospecific Antibodies Against A Subunit Of Fibrinogen
  • Method For Molecular Diagnosis Of Tumor Angiogenesis And Metastasis
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Use Of Low Temperature And/Or Low Ph In Cell Culture
  • Compositions For Inhibiting Masp-2 Dependent Complement Activation
  • A Method For The Preparation Of A Monoclonal Antibody Against Oligomeric Alpha - Synuclein
  • Methods Of Improving Vaccine Immunogenicity
  • Methods And Compositions For Analyzing Proteins
  • Anti-Ox40 Antibodies And Methods Of Use
  • Antibody Formulations
  • Signal Biomarkers
  • Method Of Dissolving Venous Thrombi Using Drug Containing Activated Protein C
  • Method Of Control Leukocyte Extravasation
  • Haptens, Tracers, Immunogens And Antibodies For 3-Phenyl-1-Adamantaneacetic Acids
  • Assays And Reagents For Amyloid Deposition
  • Monoclonal Antibody To Human Carcinomas
  • Methods For Stimulating Hematopoietic Progenitors Using Hepatocyte Growth Factor And Lymphokines
  • Nucleic Acids Encoding Murine And Human Ah Receptors
  • Chimeric Protein That Has A Human Rho Motif And Deoxyribonuclease Activity
  • Therapeutic Targets In Cancer
  • Methods For Decreasing Immune Response And Treating Immune Conditions
  • Dioxanes And Uses Thereof
  • Methods Of Expressing Lim Mineralization Protein In Non-Osseous Cells
  • Methods For Treatment Of Severe Acute Respiratory Syndrome (Sars)
  • Her-2 Binding Antagonists
  • Immunizing Compositions And Methods Of Use
  • Immunizing Compositions And Methods Of Use
  • Structural Variants Of Antibodies For Improved Therapeutic Characteristics
  • Assessment Of Skeletal Growth Using Measurements Of Nt-Cnp Peptides
  • Kid31 And Antibodies That Bind Thereto
  • Cyclic Molecular Framework And Derivatives Thereof
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Elemental Analysis Of Tagged Biologically Active Materials
  • Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits Of Caenorhabditis Elegans
  • Methods And Compositions For Producing An Enhanced Immune Response To A Human Papillomavirus Immunogen
  • Monoclonal Antibodies, Antigens And Diagnosis And Therapy Of Malignant Diseases
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Assay For Cardiac Troponin Autoantibodies
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Antibodies Directed To The Mammalian Eag1 Ion Channel Protein
  • Anti-Cd26 Antibodies And Methods Of Use Thereof
  • Methods And Compositions For Synthesis Of Nucleic Acid Molecules Using Multiple Recognition Sites
  • Antibodies Directed To Angiopoietin-1 And Angiopoietin-2 And Uses Thereof
  • Chimeric Inhibitor Molecules Of Complement Activation
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Tumor Necrosis Factor-Gamma
  • Thermostable Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Plant Artificial Chromosome (Plac) Compositions And Methods
  • Mcsp-Aligned Scfv Antibody Fragments And Use Of Same
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Humanized Anti-Amyloid Antibody
  • Human G-Protein Coupled Receptor And Ligands Thereof
  • Combination Therapy For B Cell Disorders
  • Methods For Producing Members Of Specific Binding Pairs
  • Antigen Constructs Useful In The Detection And Differentiation Of Antibodies To Hiv
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Hepatocyte Lineage Cells
  • Preprimitive Streak And Mesendoderm Cells
  • Chimeric Osteogenic Factor Containing Proteins Capable Of Increased Nuclear Localization And Methods Of Use Thereof
  • Marker Proteins For Diagnosing Liver Disease And Method Of Diagnosing Liver Disease Using The Same
  • Neisseria Meningitidis Antigenic Polypeptides, Corresponding Polynucleotides And Protective Antibodies
  • Methods Of Treating Cancer Comprising Administering An Interleukin-6 Antibody Variable Region
  • Recombinant Pr-3 And Assays Employing The Same
  • Tumor-Associated Marker
  • Mammalian Suv39h2 Proteins And Isolated Dna Molecules Encoding Them
  • Diagnosis And Treatment Of Ptp04 Related Disorders
  • Methods And Materials Relating To Novel Cd39-Like Polypeptides
  • Anti-Cd20 Antibodies And Fusion Proteins Thereof And Methods Of Use
  • Anticancer Compounds And Methods
  • Compositions And Methods For The Detection And Treatment Of Methylthioadenosine Phosphorylase Deficient Cancers
  • Methods Of Assessing Wolframin Protein Activity
  • Carrier Molecules
  • Compositions And Methods For Early Detection Of Heart Disease
  • Kits For Early Detection Of Heart Disease
  • 3′-Exonuclease, Production And Use Thereof
  • Methods And Materials Relating To Novel Cd39-Like Polypeptides
  • Regulatable Growth Of Filamentous Fungi
  • Lysin-Deficient Bacteriophages Having Reduced Immunogenicity
  • Genes And Proteins Involved In The Biosynthesis Of Enediyne Ring Structures
  • Polyalkylene Oxide-Modified Single Chain Polypeptides
  • Human Vanilloid Receptor Vr3 Protein
  • Avirulent, Immunogenic Flavivirus Chimeras
  • Gastrin Hormone Immunoassays
  • Proteins Encoded By Polynucleic Acids Of Porcine Reproductive And Respiratory Syndrome Virus (Prrsv)
  • Dnas Encoding Mammalian Histamine Receptor Of The H4 Subtype And Encoded Protein
  • Methods Of Use Of Dna Encoding A Human Histamine Receptor Of The H3 Subtype
  • Laser Inactivation Of Inhibitory Molecules In Central Nervous System Myelin
  • Identification Of Agents That Protect Against Inflammatory Injury To Neurons
  • Compositions And Methods Of Diagnosing, Monitoring, Staging, Imaging And Treating Mammary Gland Cancer
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Polynucleotide And Polypeptide Sequences Of Canine Cathepsin S
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Methods Of Determining Cellular Chemosensitivity
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Novel Compounds Derived From Neisseria Meningitidis
  • Method For Making Monoclonal Antibodies And Cross-Reactive Antibodies Obtainable By The Method
  • Methods And Materials Relating To Novel Cd39-Like Polypeptides
  • Preparation Of Factor Ix
  • Class Ii Human Histone Deacetylases, And Uses Related Thereto
  • Mammalian Adipogenic Factors
  • Inhib, A Factor Which Inhibits Cytokine-Activated Leukocytes
  • Substantially Pure Receptor Like Tgf-Β1 Binding Molecules And Uses Thereof
  • New Proteins
  • Haptens, Tracers, Immunogens And Antibodies For 3-Phenyl-1-Adamantaneacetic Acids
  • Monoclonal Antibody To Nitrotyrosine, Methods For Diagnosis And Methods For Treatment Of Disease
  • Bgl6 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Albumin Binding Antibodies And Binding Fragments Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Ultrapurified Dsba And Dsbc And Methods Of Making And Using The Same
  • Monoclonal Antibody To Human T Cells, Method For Preparing It, Hybrid Cell Line Producing It, Therapeutic Composition Comprising It And Diagnostic Method Using It
  • Antibodies That Specifically Bind Pms2
  • Cbh1 Homologs And Variant Cbh1 Cellulases
  • Method Of Detecting A Subfraction Of Probnp
  • Method And Apparatus To Identify Vulnerable Plaques With Thermal Wave Imaging Of Heated Nanoparticles
  • Methods Of Reducing A Viral Infection And Kits Therefore
  • Anti-Ngf Antibodies And Methods Using Same
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Ephb3-Specific Antibody And Uses Thereof
  • Recombinant Protein Capable Of Binding Specifically And Quickly To Troponin I Derived From Human Myocardium
  • Chimeric Ospa Genes, Proteins, And Methods Of Use Thereof
  • Chimeric Ospa Genes, Proteins, And Methods Of Use Thereof
  • Definitive Endoderm
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Isolation Of Adult Multipotential Cells By Tissue Non-Specific Alkaline Phosphatase
  • Histone Deacetylase Inhibitors
  • Monoclonal Antibodies - Idiotype - Antibody Ganglidiomab
  • Pharmacodiagnostic Test Targeting Oncology And Neurodegeneration
  • Methods For Purifying Endoderm And Pancreatic Endoderm Cells Derived From Human Embryonic Stem Cells
  • Chimeric Pcsk9 Proteins, Cells Comprising Same, And Assays Using Same
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Antigen Binding Protein And Its Use As Addressing Product For The Treatment Of Cancer
  • Compositions For Analyzing Proteins
  • Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family Member E41
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Monoclonal Antibodies Reactive With Endotoxin Core
  • Anti-Cmet Antibody
  • Pharmaceutical Preparation Containing Protein C And A Thrombolytically Active Substance
  • Bone Mineralization Proteins, Dna, Vectors, Expression Systems
  • Peptides Derived From A Retrovirus Of The Hiv Group And Their Use
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Methods And Systems For Using Rfid In Biological Field
  • Glycoprotein
  • Gitr Antigen Binding Proteins And Methods Of Use Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • High Throughput Generation And Affinity Maturation Of Humanized Antibody
  • Anti-Human Il-21 Antibodies
  • Tet2 As A Diagnostic And Pronostic Marker In Hematopoietic Neoplasms
  • Biomarkers For Determining Breast Cancer Bone Metastasis
  • Hmg1 Antibody For Treating Inflammatory Conditions
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Antigen Binding Protein And Its Use As Addressing Product For The Treatment Of Cancer
  • Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
  • Modified Polynucleotides For The Production Of Oncology-Related Proteins And Peptides
  • Dock-And-Lock (Dnl) Complexes For Therapeutic And Diagnostic Use
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Antigen Binding Proteins
  • Locating Intravascular Images
  • Antibodies Directed To Bacillus Anthracis Protective Antigen
  • Antibodies Directed Against Signal Peptides, Methods And Uses Thereof
  • Methods Of Generating Cells Exhibiting Phenotypic Plasticity
  • Antibody Specific For Clec14a And Uses Thereof
  • Intravascular Forward Imaging Device
  • Nucleic Acids Encoding Chimeric Flavivirus Immunogens Comprising The Japanese Encephalitis Virus (Jev) Prm Signal Sequence
  • Cellular Permissivity Factor For Viruses, And Uses Thereof
  • Vaccinia Virus For Diagnosis And Therapy Of Tumors
  • Antibody Composition With Altered Fab Sialylation
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Combination Of Angiopoietin-2 Antagonist And Of Vegf-A, Kdr And/Or Fltl Antagonist For Treating Cancer
  • 4-1bb Binding Molecules
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Anti-C-Met Antibody
  • Fusion Constructs And Use Of Same To Produce Antibodies With Increased Fc Receptor Binding Affinity And Effector Function
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Genetic Variants On Chr 5p12 And 10q26 As Markers For Use In Breast Cancer Risk Assessment, Diagnosis, Prognosis And Treatment
  • Multicomponent Immunogenic Composition For The Prevention Of Beta-Hemolytic Streptococcal (Bhs) Disease
  • Activin Neutralisers And Uses Thereof For Treatment Of Diseases Associated With Aberrant "Host Defence Response" Activation
  • Tcr-V-Beta Related Peptides For Treatment And Diagnosis Of Autoimmune Disease
  • Bacterial Virulence Factors And Uses Thereof
  • Breast Cancer Resistance Protein (Bcrp) Antibodies
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Labeled Peptides, Proteins And Antibodies And Processes And Intermediates Useful For Their Preparation
  • Antibodies To Interleukin-Like Epithelial-Mesenchymal Transition Inducer (Ilei)
  • Antibody-Based Therapeutics With Enhanced Adcc Activity
  • Lafora's Disease Gene
  • A Method For The Diagnosis Or Monitoring Of Cancer In A Patient
  • Nucleic Acids Encoding Chimeric Polypeptides For Library Screening
  • Haptens Of Risperidone And Paliperidone
  • Prlr-Specific Antibody And Uses Thereof
  • Human Cytomegalovirus Neutralising Antibodies And Use Thereof
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Methods Of Modulating Immune Function
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Inhibition And Treatment Of Prostate Cancer Metastasis
  • Anti-Cmet Antibody
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Methods And Compounds For Detection Of Molecular Targets
  • Anti-Neuropilin Antibodies And Methods Of Use
  • Modified Hepatitis C Virus Proteins
  • Method And Nucleic Acids For The Analysis Of Colorectal Cell Proliferative Disorders
  • Modified Polynucleotides For The Production Of G-Csf
  • Polypeptide
  • Bgl6 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Neutralizing Monoclonal Antibodies Against The Nogo-66 Receptor (Ngr) And Uses Thereof
  • Oligosaccharides And Oligosaccharide-Protein Conjugates Derived From Clostridium Difficile Polysaccharide Ps-I, Methods Of Synthesis And Uses Thereof, In Particular As Vaccines And Diagnostic Tools
  • Methods And Compositions For Prostate Cancer Metastasis
  • Anti-Loxl4 Antibodies And Derivatives There
  • Idiotypic Antibodies And Uses Thereof
  • Methods Of Treating Retinal Nerve Fiber Layer Degeneration With Monoclonal Antibodies Against A Retinal Guidance Molecule (Rgm) Protein
  • Elemental Analysis Of Tagged Biologically Active Materials
  • Modulation Of T Cell Differentiation For The Treatment Of T Helper Cell Mediated Diseases
  • Hybridoma Cell Lines And Monoclonal Antibodies Recognizing Prox1
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Protein Similar To Neuroendrocrine-Specific Protein, And Encoding Cdna
  • Thyronamine Derivatives And Analogs And Methods Of Use Thereof
  • Method For Enzymatic Production Of Decarboxylated Polyketides And Fatty Acids
  • Combination Therapy With Anti-Cd74 Antibodies Provides Enhanced Toxicity To Malignancies, Autoimmune Disease And Other Diseases
  • Stimuli-Responsive Polymer Diagnostic Assay Comprising Magnetic Nanoparticles And Capture Conjugates
  • Cancer Diagnosis And Imaging
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Methods For Reducing Intraocular Pressure By Administering A Soluble Hyaluronidase Glycoprotein (Shasegp)
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Methods For Viral Inactivation And Other Adventitious Agents
  • Anti-Folate Receptor Alpha (Fra) Antibody-Drug Conjugates And Methods Of Using Thereof
  • Antibody Producing Non-Human Mammals
  • Monoclonal Antibodies To Epizootic Hemorrhagic Disease Virus Antigen
  • Antibody Reactive To Hamster Immunoglobulins
  • A Monoclonal Antibody Specific For Myosin In The Brain
  • Variants Of Cellobiohydrolases
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Monoclonal Antibodies Against Tumor-Associated Antigens, A Process For The Preparation Thereof And The Use Thereof
  • Monoclonal Antibodies Specific For Human Basal Cell And Malignant Squamous Cell Protein, Hybridomas Therefor, Malignancy Test Methods And Diagnostic Kits
  • Monoclonal Antibodies Specific For Human Basal Cell And Malignant Squamous Cell Protein, Hybridomas Therefor, Malignancy Test Methods And Diagnostic Kits
  • Monoclonal Antibody To Human Cytotoxic And Suppressor T Cells, And Method Of Preparing It
  • Monoclonal Antibody To Human Cytotoxic And Suppressor T Cells, And Method Of Preparing It
  • Method Of Preparing Activated Protein C
  • Method For Determining The Β-Subunit Of Human Prolyl Hydroxylase By Radioimmunoassay To Detect Hepatic Disease
  • Cell Lines For Use In The Preparation Of Hybridoma Cells
  • Antibodies To Cytokinins Having A Glycosylated Isoprenoid Side Chain And Immunoassay Methods
  • Terminally Modified Rna
  • Low Cost, Portable Sensor For Molecular Assays
  • Peptides Derived From Cytotoxicity Receptor Natural Killer Protein 44 Nkp44
  • Apaf-1 An Activator Of Caspase-3
  • O-Fucosyltransferase
  • Isolation And Characterization Of The Csa Operon (Etec-Cs4 Pili) And Methods Of Using Same
  • Non-Maltogenic Exoamylases And Their Use In Retarding Retrogradation Of Starch
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Methods For Making Anterior Foregut Endoderm
  • Process For Making T Cell Hybridomas
  • Monoclonal Antibody Directed Against Cd166 And Method For Production Thereof
  • Immunoassay Of Antigens
  • Hybrid Cell Line For Producing Monoclonal Antibody To Human Thymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Hybrid Cell Line For Producing Monoclonal Antibody To Human Thymocyte Antigen, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Cc-Chemokine Binding Tick Proteins
  • Uses Of Monoclonal Antibody 8h9
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Antibody-Based Therapeutics With Enhanced Adcc Activity
  • Methods For Mediating Fibrotic Response
  • Controlled Platelet Activation To Monitor Therapy Of Adp Antagonists
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Humanized Antibody Specific For Tumor Necrosis Factor-Alpha
  • Biomarkers Of Liver Injury
  • Haptens Of Paliperidone
  • Diagnostic Antibody Assay
  • Methods And Reagents For Detecting Bioactive Lipids
  • Therapeutic Dll4 Binding Proteins
  • Uses Of Monoclonial Antibody 8h9
  • Monoclonal Antibodies To Progastrin
  • Novel Cancer Marker And Utilization Thereof
  • Haptens Of Quetiapine
  • Modulation Of Drug Resistance Via Ubiquitin Carboxy-Terminal Hydrolase
  • Identification Of Two Novel Mutant Alleles Of Human Thiopurine S-Methyltransferase, And Diagnostic Uses Thereof
  • Fluorescence Immunoassays Using Fluorescent Dyes Free Of Aggregation And Serum Binding
  • Method To Determine Metastatic Potential Of Tumor Cells
  • Hepatocyte Growth Factor Receptor Antagonists And Uses Thereof
  • Quinidine Conjugates And Their Use In Immunoassays
  • Uses Of Wnt Polypeptides
  • O-Fucosyltransferase
  • Targeted Immunostimulation With Bispecific Reagents
  • Staphylococcus Aureus Materials And Methods
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Therapeutic Epitopes And Uses Thereof
  • Flt4, A Receptor Tyrosine Kinase
  • Use Of Pairs Of Leucine Zipper Peptides In Immunoassay Methods
  • Method Of Treating Colorectal Carcinoma Lesion And Composition For Use Therein
  • Isolated Dna Encoding Human Gp2
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Metal Ion-Ligand Coordination Complexes, Antibodies Directed Thereto, And Assays Using Such Antibodies
  • Anti-Human Pulmonary Adenocarcinoma Specific Monoclonal Antibody
  • Β3 Integrin Subunit Specific Polypeptides, Cdnas Which Encode These Polypeptides And Method Of Producing These Polypeptides
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Il-6 Antagonists And Uses Thereof
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Scaffold Proteins Derived From Plant Cystatins
  • Chimeric Ospa Genes, Proteins And Methods Of Use Thereof
  • Modified Polynucleotides For The Production Of Cosmetic Proteins And Peptides
  • Processable Single Chain Molecules And Polypeptides Made Using Same
  • Guidewire Artifact Removal In Images
  • Bnp(1-32) Epitope And Antibodies Directed Against Said Epitope
  • Genetic Markers For Risk Management Of Atrial Fibrillation And Stroke
  • Surface Protein (Hbsag) Variant Of The Hepatitis B Virus
  • Serum Immunoregulatory Polypeptides And Uses Therefor
  • Methods And Compositions For Generating An Immune Response By Inducing Cd40 And Pattern Recognition Receptor Adapters
  • Zanamivir Phosphonate Congeners With Anti-Influenza Activity And Determining Oseltamivir Susceptibility Of Influenza Viruses
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • A Purified 80 Kda Protein Implicated In Abdominal Aortic Aneurysms, Antibodies Directed Thereto, And Uses Thereof
  • Β-Amyloid Peptide-Binding Proteins And Polynucleotides Encoding The Same
  • Mutations In Human Mlh1 And Human Msh2 Genes Useful In Diagnosing Colorectal Cancer
  • Methods For Identifying And Isolating Cells Expressing A Polypeptide
  • Methods And Compositions For Synthesis Of Nucleic Acid Molecules Using Multiplerecognition Sites
  • Polynucleotides Encoding Notch1 Receptor Antibodies
  • Crosslinking Of Cd22 By Epratuzumab Triggers Bcr Signaling And Caspase-Dependent Apoptosis In Hematopoietic Cancer Cells
  • Hepatocyte Lineage Cells
  • Immunizing Compositions And Methods Of Use
  • Kid3 And Kid3 Antibodies That Bind Thereto
  • Stem Cell Factor Inhibitor
  • Secreted Proteins
  • Targeting Metabolic Enzymes In Human Cancer
  • 5-Hydroxymethylcytosine In Human Cancer
  • Antibodies Which Bind To Signal Peptide-Containing Molecules
  • Dengue Virus Neutralizing Antibodies And Use Thereof
  • Antibodies For Depletion Of Icos-Positive Cells In Vivo
  • Process For Decreasing Verbascose In A Plant By Expression Of A Chloroplast-Targeted Fimd Protein
  • In Vivo Production Of Proteins
  • Method Of Modulating Inflammatory Response By Downregulation Of Activin
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Antibodies For Prevention And Treatment Of Diseases Caused By Clostridium Difficile
  • Alkynyl Sugar Analogs For Labeling And Visualization Of Glycoconjugates In Cells
  • Bispecific Anti-Vegf/Anti-Ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases
  • Optical-Electrical Rotary Joint And Methods Of Use
  • Methods For Detecting Expression Levels Of Human Signal Peptide-Containing Proteins (Hspp)
  • Combining Anti-Hla-Dr Or Anti-Trop-2 Antibodies With Microtubule Inhibitors, Parp Inhibitors, Bruton Kinase Inhibitors Or Phosphoinositide 3-Kinase Inhibitors Significantly Improves Therapeutic Outcome In Cancer
  • Anti-Tissue Factor Antibodies And Compositions
  • Purified Lymphadenopathy And Acquired Immune Deficiency Syndrome Virus And Envelope Antigens Of This Virus, Method For Obtaining This Virus And These Envelope Antigens Of This Virus, Uses Of This Virus Or Of These Antigens In The Preparation Of Immunogenic Compositions Or For The Diagnosis Of The Abovementioned Pathologies
  • Antibodies To Angiogenin: Immunotherapeutic Agents.
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
  • Monoclonal-Antibody-Producing Hybrid Cell Line, Antibody And Method Of Preparing It, Therapeutic Composition Containing It And Its Diagnostic And Therapeutic Uses
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human Monocyte Antigen, Antibody, And Methods
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human T Cell Antigen, Antibody, And Methods
  • Comb Polymers
  • Modified Amylases, Nucleic Acids Encoding Those Amylases And Uses Thereof
  • Protease-Activated Receptor 3 And Uses Thereof
  • 3′-Phosphoadenosine -5′-Phosphosulfate Synthetase 2 (Papss2) Sequence Variants
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Non-Maltogenic Exoamylases And Their Use In Retarding Retrogradation Of Starch
  • Polymer Brushes For Immobilizing Molecules To A Surface Or Substrate Having Improved Stability
  • Chimeric Retroviral Gag Genes And Screening Assays
  • Antibodies That Bind To Cancer-Associated Antigen Cd46 And Methods Of Use Thereof
  • Bone Mineralization Proteins, Dna, Vectors, Expression Systems
  • Nucleic Acid Vaccines For Prevention Of Flavivirus Infection
  • Optical Coherence Tomography System That Is Reconfigurable Between Different Imaging Modes
  • Systems And Methods For Amplifying Light
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Antibodies Specific For Tgf-Β And Methods Of Treatment Thereof
  • Immunizing Compositions And Methods Of Use
  • S. Pneumoniae Antigens
  • Combination Therapy For The Treatment Of Tumors
  • Ankyrin G And Modulators Thereof For The Treatment Of Neurodegenerative Disorders
  • Methods To Increase Or Decrease Bone Density
  • Recombinant Pr-3 And Compositions Thereof
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Fusion Proteins Comprising Carriers That Can Induce A Dual Immune Response
  • Antigenic Epitopes And Mosaic Polypeptides Of Hepatitis C Virus Proteins
  • Egviii Endoglucanase And Nucleic Acids Encoding The Same
  • Mutations Associated With Iron Disorders
  • Aortic Carboxypeptidase-Like Polypeptide
  • Hepatocyte Growth Factor Receptor Antagonists And Uses Thereof
  • Method For Screening For Drug Candidates For Modulating Transcription Factor Activity
  • Bone Mineralization Proteins, Dna, Vectors Expression Systems
  • Xylanase From Trichoderma Reesei, Method For Production Thereof, And Methods Employing This Enzyme
  • Methods And Compositions Relating To Cd39-Like Polypeptides And Nucleic Acids
  • Nuclear Matrix Protein Fluid Assay
  • Peanut Allergens And Methods
  • Polymer Brushes For Immobilizing Molecules To A Surface Or Substrate, Where The Polymers Have Water-Soluble Or Water-Dispersible Segments And Probes Bonded Thereto
  • Method, Array And Kit For Detecting Activated Transcription Factors By Hybridization Array
  • Human Adenylsuccinate Synthetase And Polynucleotides Encoding The Same
  • Prostaglandin D Synthase-Specific Monoclonal Antibody
  • Assays Involving An Il-1 Receptor Antagonist
  • Human Müllerian Duct-Derived Epithelial Cells And Methods Of Isolation And Uses Thereof
  • Purified And Recombinant Antigenic Protein Associated With Abdominal Aortic Aneurysm (Aaa) Disease, And Diagnostic And Therapeutic Use Thereof
  • Xylanase From Trichoderma Reesei , Method For Production Thereof, And Methods Employing This Enzyme
  • Complex Of Lipo-Viro-Particles, Method Of Preparation And Applications
  • Method For Measuring Cholinesterase And Method For Distinguishing Between Liver Cirrhosis And Hepatitis
  • Diagnosis Of Coeliac Disease Using A Gliadin Epitope
  • Methods For Treating An Animal For Low Milk Production
  • Polypeptides Obtained From Gram Negative Microbes
  • Nucleic Acid Fragment Encoding An Nrps For The Biosynthesis Of Anthramycin
  • Genes And Proteins Involved In The Biosynthesis Of Lipopeptides
  • Preferred Segments Of Neural Thread Protein
  • Methods For Treating Post-Surgical Pain By Administering An Anti-Nerve Growth Factor Antagonist
  • Method Of Detecting Native Probnp
  • Bgl4 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Anti-Her2 Glycoantibodies And Uses Thereof
  • Method For The Diagnosis, Prognosis And Treatment Of Lung Cancer Metastasis
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Method For Inhibiting The Immune Suppressive Function Of Human T Regulatory Cells By Administering An Anti-Garp Monoclonal Antibody
  • Decreasing Lactate Level And Increasing Polypeptide Production By Downregulating The Expression Of Lactate Dehydrogenase And Pyruvate Dehydrogenase Kinase
  • Apo-3 Polypeptide
  • Hbc Expression And Diagnostic And Therapeutic Uses
  • Methods And Materials Relating To Cd39-Like Polypeptides
  • Methods For Identifying Compounds Which Modulate Circadian Rhythm
  • Histamine-N-Methyltransferase Variants Associated With Histaminergic Disease
  • Immunoliposomes For Transmittal Of Activating Signals To Cells
  • Primitive Cell Colony Stimulating Factors Vectors, Antibodies, And Methods Of Use
  • Synthesis Of Human Procollagens And Collagens In Recombinant Dna Systems
  • Monoclonal Antibody
  • High Affinity Monoclonal Antibodies To Bowman-Birk Inhibitor And Immunoassay Methods
  • 9804 Gene And Methods Of Use Thereof
  • Method Of Purifying Recombinant Proteins From Corresponding Host Cell Proteins
  • Purification Of Plasminogen Activator Inhibitor 2 By Immunoaffinity Chromatography
  • Triasulfurone Compounds
  • Monoclonal Antibodies And Methods For Fungal Pathogen Detection
  • Monoclonal Antibodies To Bluetongue Virus Antigen
  • Secreted Streptococcus Pneumoniae Proteins
  • Immunogenic Compositions For The Prevention And Treatment Of Meningococcal Disease
  • Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-Cancer Therapy
  • Lipoprotein Associated Phospholipase A2, Inhibitors Thereof And Use Of The Same In Diagnosis And Therapy
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Methods For Detecting Oncofetal Fibronectin
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • High Affinity Nucleic Acid Ligands Of Complement System Proteins
  • Uncoupled Collagen Synthesis And Degradation Assays
  • Polypeptide Having Heparanase Activity
  • Neisserial Antigens
  • Methods And Systems For Determining The Biological Function Of Cell Constituents Using Response Profiles
  • Methods Of Treating Viral Disorders
  • Regulatory Segments Of The Human Gene For Telomerase Reverse Transcriptase
  • Polynucleotide And Protein Involved In Synaptogenesis, Variants Thereof, And Their Therapeutic And Diagnostic Uses
  • Neutralizing Monoclonal Antibodies Against The Nogo-66 Receptor (Ngr)
  • Β-Glucosidase 5 (Bgl5) Compositions
  • Methods And Compositions For Modulating T Helper (Th) Cell Development And Function
  • Relaxin-3 Chimeric Polypeptides And Their Preparation And Use
  • Differentiation Of Multi-Lineage Progenitor Cells To Hepatocytes
  • Canine Transient Receptor Potential V2 (Ctrpv2) And Methods Of Screening For Trpv2 Channel Modulators
  • Use Of Dg177 Secreted Protein Products For Preventing And Treating Pancreatic Diseases And/Or Obesity And/Or Metabolic Syndrome
  • Diagnostic And Therapeutic Epitope, And Transgenic Plant
  • Nucleic Acids Coding For Adhesion Factors Of Group B Streptococcus, Adhesion Factors Of Group B Streptococcus And Futher Uses Thereof
  • Biomarkers For Wound Healing
  • Glypican-3 (Gpc3)-Derived Tumor Rejection Antigenic Peptides Useful For Hla-A2-Positive Patients And Pharmaceutical Comprising The Same
  • Fragments Of Antibodies To Epidermal Growth Factor Receptor And Methods Of Their Use
  • Kid3 And Kid3 Antibodies That Bind Thereto
  • Nfia In Glial Fate Determination, Glioma Therapy And Astrocytoma Treatment
  • Plant Centromere Compositions
  • Nucleic Acid Encoding Scn1a Variant
  • Hiv-1 Neutralizing Antibodies And Uses Thereof
  • Communications Network System And Methods For Using Same
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Composition For Treating A Pathology Associated With Msrv/Herv-W
  • Combination Therapy For Treating Disease
  • Glycoprotein Vi And Uses Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
  • Anti-Igf-Ir Antibodies And Uses Thereof
  • Dna Methylation Markers Associated With The Cpg Island Methylator Phenotype (Cimp) In Human Colorectal Cancer
  • Borrelia Antigens
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Diagnosis Of Liver Pathology Through Assesment Of Protein Glycosylation
  • Antibodies That Bind To Psca Proteins For Diagnosis Of Cancer
  • Methods Of Purifying Fc Region Containing Proteins
  • Tumor-Associated Marker
  • Protein Similar To Neuroendocrine-Specific Protein, And Encoding Cdna
  • Sequences From Piscirickettsia Salmonis
  • F11 Receptor (F11r) Antagonists As Therapeutic Agents
  • Method To Identify A Patient With An Increased Likelihood Of Responding To An Anti-Cancer Therapy
  • Stem Cell Factor Inhibitor
  • Compositions And Methods For Diagnosing And Treating Cancer And Neurodegenerative Diseases Related To Beclin-1
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Methods For Anti-Fibrinolytic Treatment Using Mmp-10 Neutralizing Antibody
  • Isolation And Propagation Of A Human Herpesvirus Derived From Aids-Associated Kaposi's Sarcoma Cells
  • Anti-Ngf Antibodies And Methods Using Same
  • Antibody Therapy Of Tumors
  • Specific Monoclonal Antibody Against Terbinafine
  • Human Medical Treatment By Aerosol Inhalation Of Immunoglobulin A
  • Antigen Pipa And Antibodies That Bind Thereto
  • Fwd, Pp2c1, Adk3, Cg3860, Cdk4, Cg7134, Eip75b Involved In The Regulation Of Energy Homeostasis
  • Fragments And Variants Of Staphylococcus Aureus Dnag Primase, And Uses Thereof
  • Non-Affinity Purification Of Proteins
  • Detection Method Of Gynecologic Cancer
  • Compositions And Methods For Restoring Sensitivity Of Tumor Cells To Antitumor Therapy And Inducing Apoptosis
  • Treatment Of Protein Degradation Disorders
  • Human Anti-B7rp1 Neutralizing Antibodies
  • Monoclonal Antibody That Binds Human Notch2 And Notch3
  • Glypican-3 (Gpc3)-Derived Tumor Rejection Antigenic Peptides Useful For Hla-A2-Positive Patients And Pharmaceutical Comprising The Same
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Anti-Angiogenic Therapy
  • Compositions And Methods For The Treatment Of Tumor Of Hematopoietic Origin
  • H. Pylori Lipopolysaccharide Outer Core Epitope
  • Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • Soluble Hyaluronidase Glycoprotein (Shasegp), Process For Preparing The Same, Uses And Pharmaceutical Compositions Comprising Thereof
  • Induced Activation In Dendritic Cells
  • Method For Selecting A Single Cell Expressing A Heterogeneous Combination Of Antibodies
  • Antibodies To Human Β-Adrenergic Receptor Kinase
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Antibody Against Amyloid Precursor Protein Signal Peptide
  • Protein Formulation
  • Hla-Restricted, Peptide-Specific Antigen Binding Proteins
  • Anti-Human Igg1 Antibody
  • Antibody Constructs For Cdh19 And Cd3
  • Multiple Signaling Pathways Induced By Hexavalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
  • Compounds Inhibiting Cd95 Signaling For The Treatment Of Pancreatic Cancer
  • Genetic Variants Contributing To Risk Of Prostate Cancer
  • Generation Of Binding Molecules
  • Flavivirus Neutralizing Antibodies And Methods Of Use Thereof
  • Haptens Of Aripiprazole
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Catheter For In Vivo Imaging
  • Effective New Drug Target For The Treatment Of Tuberculosis
  • Method For Treating Hypophosphatemic Bone Diseases Using Fgf-23 Antibody
  • Immune Regulation Based On The Targeting Of Early Activation Molecules
  • Diagnostic Test For Vitamin B12
  • Inhibition And Treatment Of Prostate Cancer Metastasis
  • Anti-Mesothelin Antibodies
  • Chimeric T Cell Receptor Comprising Carbonic Anhydrase Ix (G250) Antibody
  • Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 2
  • Function Modifying Nav 1.7 Antibodies
  • Dlin-Kc2-Dma Lipid Nanoparticle Delivery Of Modified Polynucleotides
  • Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
  • Method For Detecting Transcription Factor-Protein Interactions
  • Methods For The Treatment Of Cancer And Inflammatory Diseases Using Cereblon As A Predictor
  • Therapeutic Composition For Treatment Of Glioblastoma
  • Method And Apparatus To Identify Vulnerable Plaques With Thermal Wave Imaging Of Heated Nanoparticles
  • Nucleic Acid Molecules Containing Recombination Sites And Methods Of Using The Same
  • Borrelia Antigens
  • Identification Of Antigen Or Ligand-Specific Binding Proteins
  • Means And Methods For Treating And/Or Preventing Natural Ahr Ligand-Dependent Cancer
  • Application Of Mrna For Use As A Therapeutic Against Tumour Diseases
  • Enzymes
  • Anti-Amyloid Antibodies And Uses Thereof
  • Peptides And Methods Using Same For Diagnosis And Treatment Of Amyloid-Associated Disease
  • Methods For Inducing Selective Apoptosis
  • Anti-Mesothelin Antibodies
  • Method For The Early Diagnosis Of Malign Tumours In Mammals And Humans
  • Method For The Early Diagnosis Of Malign Tumours In Mammals And Humans
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Beta Secretase Genes
  • Method For Reduction Of Interferences In Immunoassays
  • Angiogenesis Inhibiting Molecules, Their Selection, Production And Their Use In The Treatment Of Cancer
  • Methods Of Inducing Flavivirus Immune Responses Through The Administration Of Recombinant Flaviviruses Comprising An Engineered Japanese Encephalitis Virus Signal Sequence
  • Centromere Sequences And Minichromosomes
  • Pharmaceutical Preparation Containing Protein C And A Thrombolytically Active Substance
  • Purified Antibodies Which Specifically Bind Human Abnormal Prothrombin
  • Compositions And Methods For Treating And Diagnosing Irritable Bowel Syndrome
  • Multiplex Protein Fractionation
  • Her-3 Antibodies And Methods Of Use
  • Methods And Compositions Related To Mutant Kunitz Domain I Of Tfpi-2
  • Ionic Strength-Mediated Ph Gradient Ion Exchange Chromatography
  • Antibodies To Carcinoembryonic Antigen-Related Cell Adhesion Molecule (Ceacam)
  • Human Tumor Necrosis Factor Delta And Epsilon
  • Modified Amylases From Pseudomonas Species, Methods Of Making And Uses Thereof
  • Autoantibody Enhanced Immunoassays And Kits
  • Plants Modified With Mini-Chromosomes
  • Kid31 And Antibodies That Bind Thereto
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Methods Of Treating Diabetes And Compositions Capable Of Same
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Inositol-Phosphate Derivatives And Method Of Detecting Inositol-1-Phosphate
  • Autoantibody Enhanced Immunoassays And Kits
  • Cancerous Disease Modifying Antibodies
  • Soluble Glycosaminoglycanases And Methods Of Preparing And Using Soluble Glycosaminoglycanases
  • Autocrine Growth Factor Receptor Antibodies And Methods
  • Chimeric Antibody Against Tumor Associated Antigens And Its Use In Diagnosing Tumors
  • Labeled Peptides, Proteins And Antibodies And Processes And Intermediates Useful For Their Preparation
  • Methods For Treating Pain By Administering A Nerve Growth Factor Antagonist And An Nsaid
  • Methods To Increase Or Decrease Bone Density
  • Anti-Apoptotically Active Apatamers
  • Composition For Treating Pathology Associated With Msrv/Herv-W
  • Methods Of Preparing And Using Single Chain Anti-Tumor Antibodies
  • Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
  • Modified Rodent Parvovirus Capable Of Propagating And Spreading Through Human Gliomas
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Systems And Methods For Narrowing A Wavelength Emission Of Light
  • Methods And Assays For Measuring P95 And/Or P95 Complexes In A Sample And Antibodies Specific For P95
  • Modified Polynucleotides For The Production Of Proteins
  • Toll Like Receptor (Tlr) Stimulation For Ocular Angiogenesis And Macular Degeneration
  • Compositions Comprising Signal Peptide-Containing Proteins
  • Class- And Isoform-Specific Hdac Inhibitors And Uses Thereof
  • Binding Domains Of Proteins Of The Repulsive Guidance Molecule (Rgm) Protein Family And Functional Fragments Thereof, And Their Use
  • Infectious Clone Of Human Parvovirus B19 And Methods
  • Artificial Cell Constructs For Cellular Manipulation
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Method For Producing A Protein Of Interest In A Primate
  • Oncolytic Viruses And Methods For Treating Neoplastic Disorders
  • Methods For Treating Post-Surgical Pain By Administering An Anti-Nerve Growth Factor Antagonist Antibody
  • Aortic Carboxypeptidase-Like Polypeptide
  • Pichia Pastoris Formate Dehydrogenase And Uses Therefor
  • Alternatively Spliced Isoform Of Acetyl-Coa Carboxylase 2 (Acc2)
  • Detecting Lipocalin
  • Method Of Diagnosing, Monitoring, Staging, Imaging And Treating Gastrointestinal Cancer
  • Trichoderma Β-Glucosidase
  • Incapacitated Whole-Cell Immunogenic Bacterial Compositions
  • Determining The Effect Of A Substance On Sequestration, Uptake, And Accumulation Of Amyloid In Brain Cells
  • A Novel Surface Exposed Haemophilus Influenzae Protein (Protein E; Pe)
  • Use Of Pleitrophin For Preventing And Treating Pancreatic Diseases And/Or Obesity And/Or Metabolic Syndrome
  • Compositions For Inhibiting Masp-2 Dependent Complement Activation
  • Autocrine Growth Factor Receptor Antibodies And Methods
  • Polynucleotide And Protein Involved In Synaptogenesis Variants Thereof And Their Therapeutic And Diagnostic Uses
  • Method For Identifiying Nucleic Acid Molecules Associated With Angiogenesis
  • Zanamivir Phosphonate Congeners With Anti-Influenza Activity And Determining Oseltamivir Susceptibility Of Influenza Viruses
  • Transferrin Binding Proteins From Neisseria Gonorrhoeae And Neisseria Meningitidis
  • Methods Of Modulating C-Kit Tyrosine Protein Kinase Function With Indolinone Compounds
  • Chondrosarcoma Associated Genes
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Anti-Cd74 Immunoconjugates And Methods
  • Polyene Polyketides, Processes For Their Production And Their Use As A Pharmaceutical
  • Sequences Encoding Hepatitis C Virus Glycoproteins
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Novel Potassium Channel
  • Toxin Detection Method
  • Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
  • Methods For Improving Heart Function
  • Combination Therapy With Anti-Hla-Dr Antibodies And Kinase Inhibitors In Hematopoietic Cancers
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Methods Of Producing Two Chain Proteins In Bacteria
  • Nucleic Acids And Host Cells Expressing Antibodies Capable Of Binding To The Coagulation Factor Xia And Uses Thereof
  • Method For The Diagnosis, Prognosis And Treatment Of Breast Cancer Metastasis
  • Anti-Krs Monoclonal Antibody And Use Thereof
  • Method Of Treating Endometriosis
  • Pyrrolobenzodiazepines And Conjugates Thereof
  • Human Anti-Pd-1, Pd-L1, And Pd-L2 Antibodies And Uses Therefor
  • Pcv2b Divergent Vaccine Composition And Methods Of Use
  • Anti-Il-4/Anti-Il-13 Bispecific Antibody Formulations
  • Methods Of Treating Of Diabetes And Obesity Using Fgf21 Mutants
  • Pyrrolobenzodiazepine-Antibody Conjugates
  • Secreted Proteins
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Glycan Conjugates And Use Thereof
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Compositions Produced Using Enteric Pathogens And Methods Of Use
  • Antibodies Against Influenza Virus And Methods Of Use Thereof
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Bh3 Peptides And Methods Of Use Thereof
  • Cell Culture Compositions With Antioxidants And Methods For Polypeptide Production
  • Antigenic Gm-Csf Peptides And Antibodies To Gm-Csf
  • Anti-Sortilin Antibodies And Methods Of Use Thereof
  • Methods For The Manufacture Of Proteolytically Processed Polypeptides
  • Lymphokine In The Pure State, Monoclonal Antibodies, Hybridoma Cell Lines, Processes And Applications
  • Monoclonal Antibody To Human T Cells, Method For Preparing It, Hybrid Cell Line Producing It, Therapeutic Composition Comprising It And Diagnostic Method Using It
  • Monoclonal Antibodies Specific For Myosin In The Brain
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Methods And Compositions For Generating An Immune Response By Inducing Cd40 And Pattern Recognition Receptor Adapters
  • Monoclonal Antibodies To Anthracyclines
  • Antibodies To Human Cancer Nucleolar Antigen Pl20, Corresponding Cell Lines, And Their Preparation And Use In The Detection Of Human Cancer Cells
  • Anti Hla-G Specific Antibodies
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Aegyptin And Uses Thereof
  • Cell Culture Media And Methods Of Antibody Production
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Using Phage Epitopes To Profile The Immune Response
  • Modulators Of Itch Ubiquitinase Activity
  • Compositions And Methods For Dengue Virus Chimeric Constructs In Vaccines
  • Histone Deacetylase Inhibitors
  • Compositions And Methods Relating To Argininosucccinate Synthetase
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Foxc1 Antibodies And Methods Of Their Use
  • Sequences From Piscirickettsia Salmonis
  • Nucleotide Sequence Encoding A Mammary Cell Growth Inhibitor
  • Method Of Stimulating Bone Marrow Regeneration
  • Therapeutic Dll4 Binding Proteins
  • Porcine Leptin Protein, Nucleic Acid Sequences Coding Therefor And Uses Thereof
  • Anti-Interleukin-1 Receptor Antagonist Antibodies And Uses Thereof
  • Methods And Compositions For Gamma-Secretase Assay
  • Homeobox Gene
  • Method For Measurement Of Hepatitis C Virus
  • Preparation For Treating And Preventing Thromboses And Thromboembolic Complications, Use Of Such A Preparation And A Method Of Producing The Same
  • Sgp130/Fc Dimers
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Benzocyclooctyne Compounds And Uses Thereof
  • Filipil Compositions And Methods For Treating Cancer
  • Magneto-Motive Ultrasound Detection Of Magnetic Nanoparticles
  • Novel Methods For The Stabilisation Of Immunoglobulin Constant Domains
  • Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
  • Soluble Gp130 Muteins With Improved Binding Activity
  • Uses Of Monoclonal Antibody 8h9
  • Methods And Compositions For Generating An Immune Response By Inducing Cd40 And Pattern Recognition Receptor Adapters
  • Non-Hla Matched Humanized Nsg Mouse Model With Patient-Derived Xenograft
  • Use Of Anti-Cd83 Agonist Antibodies For Treating Autoimmune Diseases
  • Neisseria Meningitidis Compositions And Methods Thereof
  • Human Anti-Alpha-Synuclein Antibodies
  • Mdr E. Coli Specific Antibody
  • Antibodies To Quetiapine Haptens And Use Thereof
  • Antibody Fc Variants
  • Chaperonin 10 Variants
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Encapsulation Of Pancreatic Cells Derived From Human Pluripotent Stem Cells
  • Dna Encoding Antibody Molecules Which Bind Il-17a And Il-17f
  • Chimeric Fibroblast Growth Factors With Altered Receptor Specificity
  • Method For The Diagnosis And Prognosis Of Malignant Diseases
  • Markers Of Definitive Endoderm
  • Cellular Permissivity Factor For Viruses And Uses Thereof
  • Antibodies That Block Receptor Protein Tyrosine Kinase Activation, Methods Of Screening For And Uses Thereof
  • Susceptibility Variants For Lung Cancer
  • Pyrrolobenzodiazepine-Anti-Cd22 Antibody Conjugates
  • Haptens Of Aripiprazole
  • Method Of Treating Cancer By Administering A Monoclonal Antibody That Binds Human Notch2 And Notch3
  • Modified Polynucleotides Encoding Aquaporin-5
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Human Β-Adrenergic Receptor Kinase Polypeptide And Methods
  • Allergen Microarray
  • Neisserial Antigens
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Influenza Virus Vaccine Composition And Methods Of Use
  • Genetic Susceptibility Variants Associated With Cardiovascular Disease
  • B-Type Plexin Antagonists And Uses Thereof
  • Unsolvated Benzodiazepine Compositions And Methods
  • Methods Of Determining Patient Response By Measurement Of Her-3 And P95
  • Antibody Producing Non-Human Mammals
  • Markers Of Definitive Endoderm
  • Dna Encoding Function Modifying Nav1.7 Antibodies
  • Multimodal Segmentation In Intravascular Images
  • Tweak Receptor
  • Monoclonal Antibody Against Human Tau Protein
  • Bacterial Virulence Factors And Uses Thereof
  • Genetically Altered Antibody-Producing Cell Lines With Improved Antibody Characteristics
  • Compositions And Methods In Cancer Associated With Altered Expression Of Prlr
  • Bgl4 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Detection Of Von-Willebrand Factor (Vwf) Activity
  • S. Pneumoniae Antigens
  • Methods For Producing Members Of Specific Binding Pairs
  • Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/Pathogen-Derived Antigen Complexes And Uses Thereof
  • Method For Predicting Responsiveness Of Breast Cancer To Antiestrogen Therapy
  • Genetic Variants For Breast Cancer Risk Assessment
  • Antibodies That Bind The Glutamate Ligand Binding Region Of Notch3
  • Methods Of Generating Hybrid/Chimeric Cells, And Uses Thereof
  • Method To Generate Antibodies To Ion Channels
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Deacetylase Inhibitors And Uses Thereof
  • B7-H1 Antibodies And Method Of Use
  • Method Of Treatment Of A Solid Tumor With Interleukin-1 Accessory Protein Antibody
  • Methods For Treating A Disease Characterized By An Excess Of Hyaluronan By Administering A Soluble Hyaluronidase Glycoprotein (Shasegp)
  • Histone Deacetylases, And Uses Related Thereto
  • Monoclonal Antibodies Against Osteopontin
  • Methods And Compositions For Detection Of Ehrlichia Chaffeensis (Vlpt)
  • Antibody For The Diagnosis And/Or Prognosis Of Cancer
  • Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Removal Of A-Scan Streaking Artifact
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Method Of Detecting Phosphorylation State Of Beta-Catenin
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same
  • Flattop (Fltp) Is A Novel Biomarker For Beta Cell Maturation
  • Multivalent Fibronectin Based Scaffold Domain Proteins
  • Methods Of Inducing An Immune Response In A Host By Administering Flavivirus Immunogens Comprising Extracellular Viral Particles Composed Of The Premembrane (Prm) And Envelope (E) Antigens
  • Antibodies Inhibiting C-Met Dimerization, And Uses Thereof
  • Means And Methods For Treating Or Preventing Brain Tumors Based On The Nuclear Receptor Tailless (Tix)
  • Method For Preparation Of Single Chain Antibodies
  • Fgf21 Mutants And Uses Thereof
  • Chimeric Pcsk9 Proteins, Cells Comprising Same, And Assays Using Same
  • Cell Preparations Depleted Of Tcr Alpha/Beta
  • Therapeutic Dll4 Binding Proteins
  • Iron-Zinc Binding Control Factor, And Technique For Improving Iron Deficiency Tolerance Of Plant And Enhancing Iron And Zinc Accumulation In Edible Part Thereof By Controlling Expression Of Novel Iron-Zinc Binding Control Factor
  • Angiogenesis Inhibiting Molecules, Their Selection, Production And Their Use In The Treatment Of Cancer
  • Method For Controlling O-Desulfation Of Heparin
  • Monoclonal Antibodies Against Tumor-Associated Antigens, A Process For The Preparation Thereof And The Use Thereof
  • Antigenic Epitopes Present On Membrane-Bound But Not Secreted Iga
  • Polynucleotides Encoding Signal Peptide-Containing Molecules
  • Detection Of Antibodies To Squalene In Serum
  • Methods For Producing Members Of Specific Binding Pairs
  • Methods For Using Anti-Αvβ3 Integrin Antibody
  • Antibody To Aminoterminal Propeptide Of Type 1 Procollagen
  • Monoclonal Antibody Against Human Β2-Glycoprotein I And Use Thereof
  • Antibody To Secreted Polypeptide
  • Cell-Based Methods For Coupling Protein Interactions And Binding Molecule Selection And Diversification
  • Method For The Treatment Of Multiple Sclerosis By Inhibiting Il-17 Activity
  • A Method For The Production Of Recombinant Monoclonal Antibodies From Memory - B - Lymphocytes
  • Human M2e Peptide Immunogens
  • Structural Variants Of Antibodies For Improved Therapeutic Characteristics
  • Extracellular Matrix Metalloproteinase Inducer (Emmprin) Peptides And Binding Antibodies
  • Production Of Proteins In Glutamine-Free Cell Culture Media
  • Prostate Cancer Diagnosis And Treatment
  • Therapy For Liver Disease
  • Anti-Cd74 Immunoconjugates And Methods
  • Plants Modified With Mini-Chromosomes
  • Immunogenic Epitopes, Peptidomimetics, And Anti-Peptide Antibodies, And Methods Of Their Use
  • Hydrophilic Self-Immolative Linkers And Conjugates Thereof
  • Combination Therapies Comprising Anti-Erbb3 Agents
  • Systems And Methods For Generating Images Of Tissue
  • Adam-9 Modulators
  • Histone Deacetylases, And Uses Related Thereto
  • Function Of Gpr4 In Vascular Inflammatory Response To Acidosis And Related Methods
  • Rat Hepatocyte Monoclonal Antibody In Hepatocarcinogenesis
  • Influenza Virus Vaccine Composition And Methods Of Use
  • Monoclonal Antibody For App
  • Antibodies That Bind To Epha2 And Methods Of Use Thereof
  • Monoclonal Antibodies Reactive With Endotoxin Core.
  • Antibodies Binding To Polypeptides Encoded By Developmentally-Regulated Endothelial Cell Locus-1
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Human Histamine Receptor Of The H3 Subtype
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Epitopes Related To Coeliac Disease
  • Enhancement Of Immune Responses By 4-1 Bb-Binding Agents
  • Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
  • Method And Kit For Isolating Dna Probes That Bind To Activated Transcription Factors
  • Linker System For Activating Surfaces For Bioconjugation
  • Targeted Therapeutic Delivery Of Vitamin D Compounds
  • Human Ovarian Mesothelial Cells And Methods Of Isolation And Uses Thereof
  • Compositions And Methods For Identifying Agents Which Regulate Autolytic Processes In Bacteria
  • Treatment Of Metastatic Disease
  • Antibodies To Vpf
  • Methods And Compounds For Modulating Male Fertility
  • Method Of Diagnosing, Monitoring, Staging, Imaging And Treating Colon Cancer
  • Proteins Encoded By Polynucleic Acids Of Porcine Reproductive And Respiratory Syndrome Virus (Prrsv)
  • Methods And Compositions Of Matter Concerning April/G70, Bcma, Blys/Agp-3 And Taci
  • Cytokine Receptor And Nucleic Acids Encoding The Same
  • Polymer Brushes For Immobilizing Molecules To A Surface And Having Water-Soluble Or Water-Dispersible Segments Therein And Probes Bonded Thereto
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Anti-Ige Antibodies
  • Methods For Diagnostic And/Or Treatment Of Antiphospholipids Antibodies-Related Diseases, And Devices
  • Methods For Treating Breast Cancer Using Mammastatin
  • Treatment For Inflammatory Bowel Disease With A Vcam-1/1gg Fusion Protein
  • Androgen-Metabolic Gene Mutations And Prostate Cancer Risk
  • Methods For Preventing And Treating Fibrotic Diseases Resulting From Accumulation Of Excess Extracellular Matrix Induced By Tgfβ Using Renin Inhibitors
  • Nucleic Acid Encoding Amyloid Precursor-Like Protein And Uses Thereof
  • Nucleic Acid And Amino Acid Sequences For Mammalian Sulfonylurea Receptor
  • Internally Controlled Virion Nucleic Acid Amplification Reaction For Quantitation Of Virion And Virion Nucleic Acid
  • Assay Method For Screening For Inhibitors Of Protnf Conversion
  • Intranasal Immunization Against Viral Infection Using Viral Glycoprotein Subunit Vaccine
  • Serum Immunoregulatory Polypeptides And Uses Therefor
  • Monospecific Antibodies Against A Subunit Of Fibrinogen
  • Anticancer Compounds And Methods
  • Process For The Production Of Anti-Human Protein Antibody
  • Identification Of A New Member Of The Cytochrome P450 3a (Cyp3a) Gene Family: Cyp3ax
  • Method Of Detecting Axonally-Derived Protein Tau In Patients With Traumatic Cns Injury
  • Interleukin—1 Receptor Antagonist And Uses Thereof
  • Ikaros Isoforms And Mutants
  • Mutations Associated With Iron Disorders
  • Identification Of Agents That Protect Against Inflammatory Injury To Neurons
  • Methods Of Modulating Lipid Metabolism And Storage
  • Nitroaromatic Compounds For The Detection Of Hypoxia
  • Canine Factor Viii Gene, Protein And Methods Of Use
  • Assay For Marker Of Human Polymorphonuclear Leukocyte Elastase Activity
  • Method Of Screening For An Agent That Inhibits Mononuclear Phagocyte-Plaque Component Complex Formation
  • Screening Assays For Compounds
  • Use Of Human Protein C For Prevention And Treatment Of Depositions Of Thrombocytes
  • Cd2-Binding Domain Of Lymphocyte Function Associated Antigen 3
  • Certain Pyridyl And Isoquinolyl Carbinolamine Derivatives
  • Chimeric Protein That Has A Human Rho Motif And Deoxyribonuclease Activity
  • Particle Bound Binding Component Immunoassay
  • Epithelial Cell Specific Differentiation Marker
  • Autoantibodies Which Enhance The Rate Of A Chemical Reaction
  • Met Fab And Scfv Fragments
  • Antibodies Which Bind Selectively To Hair Of Animals And An Antibody Based Drug Delivery System For Animals
  • Dendritic Cell Inhibitory Proteins From Ticks
  • Novel Compounds
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Isolated Antibodies Against Biologically Active Leptin-Related Peptides
  • Methods And Nucleic Acids For Analysis Of Cellular Proliferative Disorders
  • Circovirus Sequences Associated With Piglet Weight Loss Disease (Pwd)
  • 5.9 Kda Peptide Immunoassay Method
  • Antibodies Directed Against Amyloid-Beta Peptide
  • Chromosome 13-Linked Breast Cancer Susceptibility Gene
  • Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
  • Gpr30 Estrogen Receptor In Breast Cancers
  • Antigenic Hiv Gp41 Chimeric Polypeptides Comprising The Mvp5180/91 Epitope Skgklis
  • Therapeutic Targets In Cancer
  • Tumor Necrosis Factor-Gamma
  • Microarray And Uses Therefor
  • Nucleic Acid Molecules Encoding Transmembrane Serine Proteases, The Encoded Proteins And Methods Based Thereon
  • Monoclonal Antibodies To Human Ctla-8 (Il-17a)
  • Junctional Adhesion Molecule-C (Jam-C) Binding Compounds And Methods Of Their Use
  • Feeding Formula Appliance
  • Variant Hypocrea Jecorina Cbh1 Cellulases
  • Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
  • Novel Modulators Of Trail Signalling
  • Method For Treating Or Preventing Sclerotic Disorders Using Cd-2 Binding Agents
  • Exocrine Gland Tight Junction-Constituting Protein Jeap Family
  • Methods Of Purifying Anti A Β Antibodies
  • Medical Devices And Methods For Local Delivery Of Angiotensin Ii Type 2 Receptor Antagonists
  • Monoclonal Antibodies Against Osteopontin
  • Method For Distinguishing Mesenchymal Stem Cell Using Molecular Marker And Use Thereof
  • Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
  • Uses Of Monoclonal Antibody 8h9
  • Uses Of Monoclonal Antibody 8h9
  • Engineered Anti-Cd20 Antibody Fragments For In Vivo Targeting And Therapeutics
  • Methods And Nucleic Acids For The Analyses Of Cellular Proliferative Disorders
  • Methods For Treating Conditions Associated With The Accumulation Of Excess Extracellular Matrix
  • Methods For Producing Members Of Specific Binding Pairs
  • Compositions And Methods In Cancer Associated With Altered Expression Of Kcnj9
  • Dengue Virus Neutralizing Antibodies And Uses Thereof
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Hedgehog And Patched Antagonists For Inhibiting Cell And Tissue Growth And Differentiation And Uses Therefor
  • Antibodies To Oncostatin M Receptor
  • Polypeptide
  • Nucleic Acids Coding For Antibodies Against Human Il-21 Receptor And Uses Therefor
  • Anti-Bv8 Antibodies And Uses Thereof
  • Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus
  • Vaccine For B-Cell Malignancies
  • Cancerous Disease Modifying Antibodies
  • Split Dose Administration
  • Methods And Nucleic Acids For The Analysis Of Gene Expression Associated With The Development Of Prostate Cell Proliferative Disorders
  • Fgf21 Polypeptides Comprising Two Or More Mutations And Uses Thereof
  • Method For Producing And Obtaining Variable Domains Of Anti-Digoxin Monoclonal Antibody Fab Fragment Using The Molecular Biology Cloning Technique
  • Antibodies To Paliperidone And Use Thereof
  • Methods And Compositions For The Treatment Of Antibody Mediated Neuropathies
  • Anti-Cxcr4 Antibodies And Their Use For The Treatment Of Cancer
  • Formulation And Delivery Of Plga Microspheres
  • Antibodies To Il-1r1
  • Methods For Treating Bone Cancer By Administering A Nerve Growth Factor Antagonist Antibody
  • Anti-Nucleolin Agent-Conjugated Nanoparticles
  • Hybrid Cell Line For Producing Monoclonal Antibody To A Human T Cell Antigen, Antibody, And Methods
  • Nucleic Acid Molecules Containing Recombination Sites And Methods Of Using The Same
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • 2,5-Diketo-L-Gluconic Acid Reductases And Methods Of Use
  • Sorghum Centromere Sequences And Minichromosomes
  • Novel Cytotoxic Agents For Conjugation Of Drugs To Cell Binding Molecule
  • Exo-Specific Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • B7-H1 And Methods Of Diagnosis, Prognosis, And Treatment Of Cancer
  • Antigen-Presenting Complex-Binding Compositions And Uses Thereof
  • Compounds Binding To Jmjd6 With Antifibrotic Activity
  • Hybrid Cell Line For Producing Complement-Fixing, Monoclonal Antibody To Human Suppressor T Cells, Antibody, Method Of Preparation Of This Antibody, Diagnostic And Therapeutic Uses And Pharmaceutical Compositions Comprising This Antibody
  • Methods Of Treating Pain By Inhibition Of Vgf Activity
  • Sequential Oligonucleotide Syntheses Using Immunoaffinity Techniques
  • Nucleotide, Deduced Amino Acid Sequence, Isolation And Purification Of Heat-Shock Chlamydial Proteins
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Bgl5 Β-Glucosidase And Nucleic Acids Encoding The Same
  • Rapid And Sensitive Method For Detection Of Biological Targets
  • Composition And Method For The Diagnosis And Treatment Of Iron-Related Disorders
  • Hybridomas And Monoclonal Paratopic Molecules To Apolipoprotein A-I
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Modified Caspase Polypeptides And Uses Thereof
  • Humanized Anti Cxcr4 Antibodies For The Treatment Of Cancer
  • Antibodies To Angiogenin: Immunotherapeutic Agents.
  • Anti-Pdgf-C Antibodies
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/256495a0

    DOI

    http://dx.doi.org/10.1038/256495a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1001387921

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/1172191


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibody Formation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibody Specificity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Fusion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Culture Techniques", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Erythrocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genetic Code", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred BALB C", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Multiple Myeloma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Spleen", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "familyName": "K\u00d6HLER", 
            "givenName": "G.", 
            "type": "Person"
          }, 
          {
            "familyName": "MILSTEIN", 
            "givenName": "C.", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/205640a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001120649", 
              "https://doi.org/10.1038/205640a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/205640a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001120649", 
              "https://doi.org/10.1038/205640a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/244042a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004074762", 
              "https://doi.org/10.1038/244042a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.71.6.2203", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007851105"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0014-4827(70)90489-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008893882"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/252354a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020752516", 
              "https://doi.org/10.1038/252354a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/219066a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021244471", 
              "https://doi.org/10.1038/219066a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/eji.1830030305", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028187016"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1280427", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050611617"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1280427", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050611617"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.140.3565.405", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062479878"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.145.3633.709", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062483252"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1152/physrev.1972.52.3.631", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1080437434"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1975-08", 
        "datePublishedReg": "1975-08-01", 
        "description": "THE manufacture of predefined specific antibodies by means of permanent tissue culture cell lines is of general interest. There are at present a considerable number of permanent cultures of myeloma cells1,2 and screening procedures have been used to reveal antibody activity in some of them. This, however, is not a satisfactory source of monoclonal antibodies of predefined specificity. We describe here the derivation of a number of tissue culture cell lines which secrete anti-sheep red blood cell (SRBC) antibodies. The cell lines are made by fusion of a mouse myeloma and mouse spleen cells from an immunised donor. To understand the expression and interactions of the Ig chains from the parental lines, fusion experiments between two known mouse myeloma lines were carried out.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/256495a0", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0090-0028", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5517", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "256"
          }
        ], 
        "name": "Continuous cultures of fused cells secreting antibody of predefined specificity", 
        "pagination": "495-497", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "069c499d4bb0d438c6a833161c969c43eb28248be5c0ba53729b77fa0218f92c"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "1172191"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0410462"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/256495a0"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1001387921"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/256495a0", 
          "https://app.dimensions.ai/details/publication/pub.1001387921"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-10T14:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000421.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://www.nature.com/articles/256495a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/256495a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/256495a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/256495a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/256495a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    158 TRIPLES      21 PREDICATES      53 URIs      34 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/256495a0 schema:about N00b02625c45249039cee47289ee8cd09
    2 N16525f49bcff40c5ad2142956d7dd975
    3 N1f09f27ea6ee4579883b13d6f6f9f958
    4 N2cf705e60d144614972010b24c38cd50
    5 N2e6f649d987847a995d91122e21e7d2e
    6 N31ade16c8dd14f349865737253f38be8
    7 N4673a9f0c796440e9bfca9a2282e582a
    8 N4dc70999932044659ac695099863b30a
    9 N7a28beac4b1c4261bd3177da015baf53
    10 Na0b00b632b1e4ec694443da3f21b4c76
    11 Na6ba0947c11b4c02b6221a5a54e063f5
    12 Nd1aa806e20e6403298187a8f691a9dc2
    13 Nd837b7e35f8d45caaa5ca42bd557e2c7
    14 anzsrc-for:11
    15 anzsrc-for:1107
    16 schema:author N1f043b1385c54d83bde744e0343485a2
    17 schema:citation sg:pub.10.1038/205640a0
    18 sg:pub.10.1038/219066a0
    19 sg:pub.10.1038/244042a0
    20 sg:pub.10.1038/252354a0
    21 https://doi.org/10.1002/eji.1830030305
    22 https://doi.org/10.1016/0014-4827(70)90489-1
    23 https://doi.org/10.1042/bj1280427
    24 https://doi.org/10.1073/pnas.71.6.2203
    25 https://doi.org/10.1126/science.140.3565.405
    26 https://doi.org/10.1126/science.145.3633.709
    27 https://doi.org/10.1152/physrev.1972.52.3.631
    28 schema:datePublished 1975-08
    29 schema:datePublishedReg 1975-08-01
    30 schema:description THE manufacture of predefined specific antibodies by means of permanent tissue culture cell lines is of general interest. There are at present a considerable number of permanent cultures of myeloma cells1,2 and screening procedures have been used to reveal antibody activity in some of them. This, however, is not a satisfactory source of monoclonal antibodies of predefined specificity. We describe here the derivation of a number of tissue culture cell lines which secrete anti-sheep red blood cell (SRBC) antibodies. The cell lines are made by fusion of a mouse myeloma and mouse spleen cells from an immunised donor. To understand the expression and interactions of the Ig chains from the parental lines, fusion experiments between two known mouse myeloma lines were carried out.
    31 schema:genre research_article
    32 schema:inLanguage en
    33 schema:isAccessibleForFree false
    34 schema:isPartOf N45920d1e601a4808bc33a2f1acd44be4
    35 N555b4d63ff0b424db63847966c2f7dc0
    36 sg:journal.1018957
    37 schema:name Continuous cultures of fused cells secreting antibody of predefined specificity
    38 schema:pagination 495-497
    39 schema:productId N04db0f31adbf4b48a47d30370ff03bb9
    40 N0a5b47dc293f4d9e8ea09e1ad329ec91
    41 N1766fa28ea3c4408af1a396b811f42e0
    42 N2f7153817f9640caa006c90a43abe5c2
    43 Ne46404746c0745759288730cc029961b
    44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001387921
    45 https://doi.org/10.1038/256495a0
    46 schema:sdDatePublished 2019-04-10T14:47
    47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    48 schema:sdPublisher N48eeb2dc49d64ae2bb3655aa8f0aec1a
    49 schema:url http://www.nature.com/articles/256495a0
    50 sgo:license sg:explorer/license/
    51 sgo:sdDataset articles
    52 rdf:type schema:ScholarlyArticle
    53 N00b02625c45249039cee47289ee8cd09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    54 schema:name Immunoglobulins
    55 rdf:type schema:DefinedTerm
    56 N04db0f31adbf4b48a47d30370ff03bb9 schema:name pubmed_id
    57 schema:value 1172191
    58 rdf:type schema:PropertyValue
    59 N0a5b47dc293f4d9e8ea09e1ad329ec91 schema:name doi
    60 schema:value 10.1038/256495a0
    61 rdf:type schema:PropertyValue
    62 N16525f49bcff40c5ad2142956d7dd975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    63 schema:name Antibody Formation
    64 rdf:type schema:DefinedTerm
    65 N1766fa28ea3c4408af1a396b811f42e0 schema:name nlm_unique_id
    66 schema:value 0410462
    67 rdf:type schema:PropertyValue
    68 N1f043b1385c54d83bde744e0343485a2 rdf:first Nba53cd98c64e4bff8d242c4c863b028b
    69 rdf:rest N6f15acbc57d7465cb23b71406bfb42e9
    70 N1f09f27ea6ee4579883b13d6f6f9f958 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    71 schema:name Erythrocytes
    72 rdf:type schema:DefinedTerm
    73 N2cf705e60d144614972010b24c38cd50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    74 schema:name Cell Fusion
    75 rdf:type schema:DefinedTerm
    76 N2e6f649d987847a995d91122e21e7d2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    77 schema:name Mice
    78 rdf:type schema:DefinedTerm
    79 N2f7153817f9640caa006c90a43abe5c2 schema:name dimensions_id
    80 schema:value pub.1001387921
    81 rdf:type schema:PropertyValue
    82 N31ade16c8dd14f349865737253f38be8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    83 schema:name Antibody Specificity
    84 rdf:type schema:DefinedTerm
    85 N45920d1e601a4808bc33a2f1acd44be4 schema:issueNumber 5517
    86 rdf:type schema:PublicationIssue
    87 N4673a9f0c796440e9bfca9a2282e582a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name Cell Line
    89 rdf:type schema:DefinedTerm
    90 N48eeb2dc49d64ae2bb3655aa8f0aec1a schema:name Springer Nature - SN SciGraph project
    91 rdf:type schema:Organization
    92 N4dc70999932044659ac695099863b30a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    93 schema:name Animals
    94 rdf:type schema:DefinedTerm
    95 N555b4d63ff0b424db63847966c2f7dc0 schema:volumeNumber 256
    96 rdf:type schema:PublicationVolume
    97 N6f15acbc57d7465cb23b71406bfb42e9 rdf:first N7b244e807972485c9fcc19789ca91d5a
    98 rdf:rest rdf:nil
    99 N7a28beac4b1c4261bd3177da015baf53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    100 schema:name Mice, Inbred BALB C
    101 rdf:type schema:DefinedTerm
    102 N7b244e807972485c9fcc19789ca91d5a schema:familyName MILSTEIN
    103 schema:givenName C.
    104 rdf:type schema:Person
    105 Na0b00b632b1e4ec694443da3f21b4c76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Genetic Code
    107 rdf:type schema:DefinedTerm
    108 Na6ba0947c11b4c02b6221a5a54e063f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Culture Techniques
    110 rdf:type schema:DefinedTerm
    111 Nba53cd98c64e4bff8d242c4c863b028b schema:familyName KÖHLER
    112 schema:givenName G.
    113 rdf:type schema:Person
    114 Nd1aa806e20e6403298187a8f691a9dc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Multiple Myeloma
    116 rdf:type schema:DefinedTerm
    117 Nd837b7e35f8d45caaa5ca42bd557e2c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Spleen
    119 rdf:type schema:DefinedTerm
    120 Ne46404746c0745759288730cc029961b schema:name readcube_id
    121 schema:value 069c499d4bb0d438c6a833161c969c43eb28248be5c0ba53729b77fa0218f92c
    122 rdf:type schema:PropertyValue
    123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    124 schema:name Medical and Health Sciences
    125 rdf:type schema:DefinedTerm
    126 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    127 schema:name Immunology
    128 rdf:type schema:DefinedTerm
    129 sg:journal.1018957 schema:issn 0090-0028
    130 1476-4687
    131 schema:name Nature
    132 rdf:type schema:Periodical
    133 sg:pub.10.1038/205640a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001120649
    134 https://doi.org/10.1038/205640a0
    135 rdf:type schema:CreativeWork
    136 sg:pub.10.1038/219066a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021244471
    137 https://doi.org/10.1038/219066a0
    138 rdf:type schema:CreativeWork
    139 sg:pub.10.1038/244042a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004074762
    140 https://doi.org/10.1038/244042a0
    141 rdf:type schema:CreativeWork
    142 sg:pub.10.1038/252354a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020752516
    143 https://doi.org/10.1038/252354a0
    144 rdf:type schema:CreativeWork
    145 https://doi.org/10.1002/eji.1830030305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028187016
    146 rdf:type schema:CreativeWork
    147 https://doi.org/10.1016/0014-4827(70)90489-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008893882
    148 rdf:type schema:CreativeWork
    149 https://doi.org/10.1042/bj1280427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050611617
    150 rdf:type schema:CreativeWork
    151 https://doi.org/10.1073/pnas.71.6.2203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007851105
    152 rdf:type schema:CreativeWork
    153 https://doi.org/10.1126/science.140.3565.405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062479878
    154 rdf:type schema:CreativeWork
    155 https://doi.org/10.1126/science.145.3633.709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062483252
    156 rdf:type schema:CreativeWork
    157 https://doi.org/10.1152/physrev.1972.52.3.631 schema:sameAs https://app.dimensions.ai/details/publication/pub.1080437434
    158 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...